{"protocolSection": {"identificationModule": {"nctId": "NCT01807221", "orgStudyIdInfo": {"id": "14564"}, "secondaryIdInfos": [{"id": "2012-002627-15", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Bayer", "class": "INDUSTRY"}, "briefTitle": "Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone", "officialTitle": "A Randomized, Double-blind, Double-dummy, Multi-center Study to Assess Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Emergency Presentation at the Hospital Because of Worsening Chronic Heart Failure With Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone Versus Eplerenone", "acronym": "ARTS-HF"}, "statusModule": {"statusVerifiedDate": "2021-07", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2013-06-17", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2014-11-11", "type": "ACTUAL"}, "completionDateStruct": {"date": "2014-12-09", "type": "ACTUAL"}, "studyFirstSubmitDate": "2013-03-07", "studyFirstSubmitQcDate": "2013-03-07", "studyFirstPostDateStruct": {"date": "2013-03-08", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2021-04-15", "resultsFirstSubmitQcDate": "2021-05-20", "resultsFirstPostDateStruct": {"date": "2021-06-15", "type": "ACTUAL"}, "dispFirstSubmitDate": "2015-06-04", "dispFirstSubmitQcDate": "2015-06-04", "dispFirstPostDateStruct": {"date": "2015-07-01", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2021-07-02", "lastUpdatePostDateStruct": {"date": "2021-07-06", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Bayer", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "To assess a new drug, BAY94-8862, given orally at different doses, to evaluate whether it was safe and can help the well-being of patients with worsening chronic heart failure and either type II diabetes with or without chronic kidney disease or kidney disease alone. These treatment doses were compared to eplerenone, another marketed drug approved to treat heart failure."}, "conditionsModule": {"conditions": ["Heart Failure"], "keywords": ["Heart Decompensation"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 1066, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Finerenone(BAY94-8862)[2.5mg] + Placebo", "type": "EXPERIMENTAL", "description": "Oral - 2.5mg once daily (OD) for 30 days. Potential up-titration to 5mg OD after 30 days or 60 days. Treatment duration 90 days. Placebo OD for 90 days.", "interventionNames": ["Drug: Finerenone (BAY94-8862)", "Drug: Placebo"]}, {"label": "Finerenone (BAY94-8862)[5mg] + Placebo", "type": "EXPERIMENTAL", "description": "Oral - 5mg OD for 30 days. Potential up-titration to 10 mg OD after 30 days or 60 days. Treatment duration 90 days. Placebo OD for 90 days.", "interventionNames": ["Drug: Finerenone (BAY94-8862)", "Drug: Placebo"]}, {"label": "Finerenone (BAY94-8862)[7.5mg] + Placebo", "type": "EXPERIMENTAL", "description": "Oral - 7.5mg OD for 30 days. Potential up-titration to 15 mg OD after 30 days or 60 days. Treatment duration 90 days. Placebo OD for 90 days.", "interventionNames": ["Drug: Finerenone (BAY94-8862)", "Drug: Placebo"]}, {"label": "Finerenone (BAY94-8862)[10mg] + Placebo", "type": "EXPERIMENTAL", "description": "Oral - 10mg OD for 30 days. Potential up-titration to 20 mg OD after 30 days or 60 days. Treatment duration 90 days. Placebo OD for 90 days.", "interventionNames": ["Drug: Finerenone (BAY94-8862)", "Drug: Placebo"]}, {"label": "Finerenone (BAY94-8862)[15mg] + Placebo", "type": "EXPERIMENTAL", "description": "Oral - 15mg OD for 30 days. Potential up-titration to 20 mg OD after 30 days or 60 days. Treatment duration 90 days. Placebo OD for 90 days.", "interventionNames": ["Drug: Finerenone (BAY94-8862)", "Drug: Placebo"]}, {"label": "Eplerenone [25 mg] + Placebo", "type": "ACTIVE_COMPARATOR", "description": "Oral - 25mg every other day (EOD). Potential up-titration to 25mg OD after 30 days and 50mg OD after 60 days.Placebo OD for 90 days.", "interventionNames": ["Drug: Placebo", "Drug: Inspra (eplerenone)"]}], "interventions": [{"type": "DRUG", "name": "Finerenone (BAY94-8862)", "armGroupLabels": ["Finerenone (BAY94-8862)[10mg] + Placebo", "Finerenone (BAY94-8862)[15mg] + Placebo", "Finerenone (BAY94-8862)[5mg] + Placebo", "Finerenone (BAY94-8862)[7.5mg] + Placebo", "Finerenone(BAY94-8862)[2.5mg] + Placebo"]}, {"type": "DRUG", "name": "Placebo", "armGroupLabels": ["Eplerenone [25 mg] + Placebo", "Finerenone (BAY94-8862)[10mg] + Placebo", "Finerenone (BAY94-8862)[15mg] + Placebo", "Finerenone (BAY94-8862)[5mg] + Placebo", "Finerenone (BAY94-8862)[7.5mg] + Placebo", "Finerenone(BAY94-8862)[2.5mg] + Placebo"]}, {"type": "DRUG", "name": "Inspra (eplerenone)", "armGroupLabels": ["Eplerenone [25 mg] + Placebo"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Percentage of Participants With a Relative Decrease in NT-proBNP of More Than 30% From Baseline to Day 90", "description": "N-terminal pro-B type natriuretic peptide (NT-proBNP) levels in the blood are used for screening, diagnosis of acute and chronic heart failure (CHF) and may be useful to establish prognosis in heart failure.", "timeFrame": "Baseline and Day 90"}], "secondaryOutcomes": [{"measure": "Number of Participants With Death Due to Any Cause", "description": "Death due to any cause include cardiovascular (CV) death and Non-CV death. Non-CV death was classified by 2 subcategories: non-malignant causes and malignant causes.", "timeFrame": "Day 30, Day 60, Day 90 and Follow-up (30 days post-last dose, assessed up to Day 120)"}, {"measure": "Number of Participants With Cardiovascular Hospitalization", "description": "Hospitalizations were defined as any unplanned admission to hospital, i.e. completion of hospital admission procedures and one overnight \\[i.e. date change\\] stay or until the death of subject occurred. Hospitalizations and deaths were classified by 2 primary categories: CV and non-CV. The pre-specified subcategories for CV hospitalizations were as follows: 1. Worsening heart failure, 2.Acute myocardial infarction, 3. Arrhythmia, 4.Transient ischemic attack and stroke, 5. Other CV hospitalizations.", "timeFrame": "Day 30, Day 60, Day 90 and Follow-up (30 days post-last dose, assessed up to Day 120)"}, {"measure": "Number of Participants With Emergency Presentations for Worsening Chronic Heart Failure (WCHF)", "description": "Emergency presentations for WCHF were defined as newly developing signs and symptoms of WCHF after start of treatment with study drug, requiring an additional emergency presentation to hospital and IV treatment with diuretics and/or positive inotropic agents.", "timeFrame": "Day 30, Day 60, Day 90 and Follow-up (30 days post-last dose, assessed up to Day 120)"}, {"measure": "Ratio of BNP at Specified Visits to BNP at Baseline", "description": "B-type natriuretic peptide (BNP) levels in the blood are used for screening, diagnosis of acute chronic heart failure (CHF) and may be useful to establish prognosis in heart failure.", "timeFrame": "Day 30, Day 60, Day 90, Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)"}, {"measure": "Ratio of NT-proBNP at Specified Visits to NT-proBNP at Baseline", "description": "N-terminal pro-B type natriuretic peptide (NT-proBNP) levels in the blood are used for screening, diagnosis of acute chronic heart failure (CHF) and may be useful to establish prognosis in heart failure.", "timeFrame": "Day 30, Day 60, Day 90, Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)"}, {"measure": "Change From Baseline in KCCQ Questionnaire Scores at Specified Visits", "description": "The Kansas City Cardiomyopathy Questionnaire (KCCQ) was the leading health related quality of life measure for subjects with CHF. KCCQ was a 23 item questionnaire that independently measures the impact of subjects HF, or its treatment, on 7 distinct domains: self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. KCCQ clinical summary score is a composite assessment of physical limitations and total symptom scores. Results from the total symptom summary score are presented. Scores are transformed to a range of 0-100, in which higher scores reflect better health status. In the below table, categorical data represents change from baseline data at respective time points.", "timeFrame": "Baseline, Day 30 and Day 90"}, {"measure": "Change From Baseline in EQ-5D-3L Questionnaire Scores at Specified Visits", "description": "EuroQol Group 5-Dimension, 3-Level (EQ-5D-3L): participant rated questionnaire to assess health-related quality of life. It consists of EQ-5D descriptive system and EQ-5D Visual Analog Scale (VAS). EQ-5D-3L descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems (1), some problems (2), and extreme problems (3). For this population, the possible EQ-5D-3L index scores ranges from -0.11 (that is, 3 for all 5 dimensions) to 1.0 (that is, 1 for all 5 dimensions), where higher scores indicate a better health state.", "timeFrame": "Baseline, Day 30, Day 90, Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)"}], "otherOutcomes": [{"measure": "Change From Baseline in Serum Potassium at Specified Visits", "timeFrame": "Baseline, Day 30, Day 60, Day 90 and Follow-up (30 days post-last dose, assessed up to Day 120)"}, {"measure": "Change From Baseline in Systolic Blood Pressure at Specified Visits", "timeFrame": "Baseline,Day 7,14,30,60,90,Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)"}, {"measure": "Change From Baseline in Diastolic Blood Pressure at Specified Visits", "timeFrame": "Baseline,Day 7,14,30,60,90,Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)"}, {"measure": "Change From Baseline in Heart Rate at Specified Visits", "timeFrame": "Baseline,Day 7,14,30,60,90,Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Men and women aged 18 years and older. The lower age limit may be higher if legally required in the participating country\n* Women of childbearing potential can only be included in the study if a pregnancy test is negative and if they agree to use adequate contraception when sexually active\n* Subjects with worsening chronic heart failure requiring emergency presentation to hospital and treatment with intravenous diuretics at hospital\n* Subjects with clinical diagnosis of chronic heart failure (CHF) either ischemic or non ischemic, New York Heart Association (NYHA) functional class II-IV\n* Subjects with type 2 diabetes mellitus and / or\n* Subjects with 30 mL/min/1.73m\\^2 \\</= eGFR \\</= 60 mL/min/1.73m\\^2 (MDRD, Modification of Diet in Renal Disease Study Group) at screening\n* Left ventricular ejection fraction (LVEF) \\</= 40%\n* Blood potassium \\</= 5.0 mmol/L at screening\n* Systolic blood pressure \\>/= 90 mmHg without signs and symptoms of hypotension at the screening visit\n\nExclusion Criteria:\n\n* Acute de-novo heart failure or acute inflammatory heart disease, e.g. acute myocarditis\n* Acute coronary syndrome (ACS) in last 30 days prior to screening\n* Cardiogenic shock\n* Valvular heart disease requiring surgical intervention during the course of the study\n* Stroke or transient ischemic cerebral attack in the last 3 months prior to the screening visit\n* Concomitant treatment with any mineralocorticoid receptor antagonist (MRA), renin inhibitor, or potassium-sparing diuretic", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Bayer Study Director", "affiliation": "Bayer", "role": "STUDY_DIRECTOR"}], "locations": [{"city": "Birmingham", "state": "Alabama", "zip": "35294-2041", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"city": "La Jolla", "state": "California", "zip": "92037", "country": "United States", "geoPoint": {"lat": 32.84727, "lon": -117.2742}}, {"city": "Los Angeles", "state": "California", "zip": "90033", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"city": "Jacksonville", "state": "Florida", "zip": "32209", "country": "United States", "geoPoint": {"lat": 30.33218, "lon": -81.65565}}, {"city": "Macon", "state": "Georgia", "zip": "31201", "country": "United States", "geoPoint": {"lat": 32.84069, "lon": -83.6324}}, {"city": "Baltimore", "state": "Maryland", "zip": "21201", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"city": "Detroit", "state": "Michigan", "zip": "48201", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"city": "Detroit", "state": "Michigan", "zip": "48202", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"city": "Newark", "state": "New Jersey", "zip": "07103", "country": "United States", "geoPoint": {"lat": 40.73566, "lon": -74.17237}}, {"city": "Fairfield", "state": "Ohio", "zip": "45014", "country": "United States", "geoPoint": {"lat": 39.34589, "lon": -84.5605}}, {"city": "Darlinghurst", "state": "New South Wales", "zip": "2010", "country": "Australia", "geoPoint": {"lat": -33.87939, "lon": 151.21925}}, {"city": "Adelaide", "state": "South Australia", "zip": "5042", "country": "Australia", "geoPoint": {"lat": -34.92866, "lon": 138.59863}}, {"city": "Concord", "zip": "2139", "country": "Australia", "geoPoint": {"lat": -33.84722, "lon": 151.10381}}, {"city": "Prahran", "zip": "3004", "country": "Australia", "geoPoint": {"lat": -37.85114, "lon": 144.99318}}, {"city": "Krems an der Donau", "state": "Nieder\u00f6sterreich", "zip": "3500", "country": "Austria", "geoPoint": {"lat": 48.40921, "lon": 15.61415}}, {"city": "Linz", "state": "Ober\u00f6sterreich", "zip": "4010", "country": "Austria", "geoPoint": {"lat": 48.30639, "lon": 14.28611}}, {"city": "Graz", "state": "Steiermark", "zip": "8020", "country": "Austria", "geoPoint": {"lat": 47.06667, "lon": 15.45}}, {"city": "Graz", "state": "Steiermark", "zip": "8036", "country": "Austria", "geoPoint": {"lat": 47.06667, "lon": 15.45}}, {"city": "Innsbruck", "state": "Tirol", "zip": "6020", "country": "Austria", "geoPoint": {"lat": 47.26266, "lon": 11.39454}}, {"city": "Salzburg", "zip": "5020", "country": "Austria", "geoPoint": {"lat": 47.79941, "lon": 13.04399}}, {"city": "Wien", "zip": "1100", "country": "Austria", "geoPoint": {"lat": 48.20849, "lon": 16.37208}}, {"city": "Burgas", "zip": "8018", "country": "Bulgaria", "geoPoint": {"lat": 42.50606, "lon": 27.46781}}, {"city": "Pazardzhik", "zip": "4400", "country": "Bulgaria", "geoPoint": {"lat": 42.2, "lon": 24.33333}}, {"city": "Ruse", "zip": "7002", "country": "Bulgaria", "geoPoint": {"lat": 43.85639, "lon": 25.97083}}, {"city": "Sofia", "zip": "1233", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"city": "Sofia", "zip": "1309", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"city": "Sofia", "zip": "1431", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"city": "Varna", "zip": "9010", "country": "Bulgaria", "geoPoint": {"lat": 43.21667, "lon": 27.91667}}, {"city": "Calgary", "state": "Alberta", "zip": "T2N 4Z6", "country": "Canada", "geoPoint": {"lat": 51.05011, "lon": -114.08529}}, {"city": "Ottawa", "state": "Ontario", "zip": "K1Y 4W7", "country": "Canada", "geoPoint": {"lat": 45.41117, "lon": -75.69812}}, {"city": "Toronto", "state": "Ontario", "zip": "M5B 1W8", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"city": "Montreal", "state": "Quebec", "zip": "H1T 1C8", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"city": "Montreal", "state": "Quebec", "zip": "H2W 1T8", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"city": "Montreal", "state": "Quebec", "zip": "H3T 1E2", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"city": "Saint-Jean-sur-Richelieu", "state": "Quebec", "zip": "J3A 1C3", "country": "Canada", "geoPoint": {"lat": 45.30713, "lon": -73.26259}}, {"city": "Sherbrooke", "state": "Quebec", "zip": "J1H 5N4", "country": "Canada", "geoPoint": {"lat": 45.40008, "lon": -71.89908}}, {"city": "Quebec", "zip": "G1V 4G5", "country": "Canada", "geoPoint": {"lat": 46.81228, "lon": -71.21454}}, {"city": "Jindrichuv Hradec", "zip": "377 01", "country": "Czechia", "geoPoint": {"lat": 49.14404, "lon": 15.00301}}, {"city": "Ostrava", "zip": "728 80", "country": "Czechia", "geoPoint": {"lat": 49.83465, "lon": 18.28204}}, {"city": "Praha 5", "zip": "150 30", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"city": "Slany", "zip": "274 01", "country": "Czechia", "geoPoint": {"lat": 50.23046, "lon": 14.08693}}, {"city": "Copenhagen \u00d8", "zip": "2100", "country": "Denmark", "geoPoint": {"lat": 55.67594, "lon": 12.56553}}, {"city": "Esbjerg", "zip": "6700", "country": "Denmark", "geoPoint": {"lat": 55.47028, "lon": 8.45187}}, {"city": "Glostrup", "zip": "2600", "country": "Denmark", "geoPoint": {"lat": 55.6666, "lon": 12.40377}}, {"city": "Hellerup", "zip": "2900", "country": "Denmark", "geoPoint": {"lat": 55.73204, "lon": 12.57093}}, {"city": "Herlev", "zip": "2730", "country": "Denmark", "geoPoint": {"lat": 55.72366, "lon": 12.43998}}, {"city": "Hvidovre", "zip": "2650", "country": "Denmark", "geoPoint": {"lat": 55.65719, "lon": 12.47364}}, {"city": "K\u00f8benhavn NV", "zip": "2400", "country": "Denmark", "geoPoint": {"lat": 55.67594, "lon": 12.56553}}, {"city": "K\u00f8ge", "zip": "4600", "country": "Denmark", "geoPoint": {"lat": 55.45802, "lon": 12.18214}}, {"city": "Svendborg", "zip": "5700", "country": "Denmark", "geoPoint": {"lat": 55.05982, "lon": 10.60677}}, {"city": "Viborg", "zip": "8800", "country": "Denmark", "geoPoint": {"lat": 56.45319, "lon": 9.40201}}, {"city": "Espoo", "zip": "02740", "country": "Finland", "geoPoint": {"lat": 60.2052, "lon": 24.6522}}, {"city": "Helsinki", "zip": "00099", "country": "Finland", "geoPoint": {"lat": 60.16952, "lon": 24.93545}}, {"city": "Rovaniemi", "zip": "96101", "country": "Finland", "geoPoint": {"lat": 66.5, "lon": 25.71667}}, {"city": "Turku", "zip": "20520", "country": "Finland", "geoPoint": {"lat": 60.45148, "lon": 22.26869}}, {"city": "Bron", "zip": "69677", "country": "France", "geoPoint": {"lat": 45.73333, "lon": 4.91667}}, {"city": "Nice", "zip": "06200", "country": "France", "geoPoint": {"lat": 43.70313, "lon": 7.26608}}, {"city": "PARIS cedex 10", "zip": "75475", "country": "France", "geoPoint": {"lat": 48.85341, "lon": 2.3488}}, {"city": "Paris cedex 13", "zip": "75013", "country": "France", "geoPoint": {"lat": 48.85341, "lon": 2.3488}}, {"city": "Rouen", "zip": "76031", "country": "France", "geoPoint": {"lat": 49.44313, "lon": 1.09932}}, {"city": "Toulouse", "zip": "31403", "country": "France", "geoPoint": {"lat": 43.60426, "lon": 1.44367}}, {"city": "Vandoeuvre les Nancy", "zip": "54500", "country": "France", "geoPoint": {"lat": 48.65, "lon": 6.18333}}, {"city": "W\u00fcrzburg", "state": "Bayern", "zip": "97078", "country": "Germany", "geoPoint": {"lat": 49.79391, "lon": 9.95121}}, {"city": "Frankfurt", "state": "Hessen", "zip": "60389", "country": "Germany", "geoPoint": {"lat": 50.11552, "lon": 8.68417}}, {"city": "Limburg", "state": "Hessen", "zip": "65549", "country": "Germany", "geoPoint": {"lat": 48.03138, "lon": 12.18221}}, {"city": "G\u00f6ttingen", "state": "Niedersachsen", "zip": "37099", "country": "Germany", "geoPoint": {"lat": 51.53443, "lon": 9.93228}}, {"city": "Hannover", "state": "Niedersachsen", "zip": "30625", "country": "Germany", "geoPoint": {"lat": 52.37052, "lon": 9.73322}}, {"city": "Stade", "state": "Niedersachsen", "zip": "21682", "country": "Germany", "geoPoint": {"lat": 53.59337, "lon": 9.47629}}, {"city": "Bad Oeynhausen", "state": "Nordrhein-Westfalen", "zip": "32545", "country": "Germany", "geoPoint": {"lat": 52.20699, "lon": 8.80365}}, {"city": "M\u00f6nchengladbach", "state": "Nordrhein-Westfalen", "zip": "41063", "country": "Germany", "geoPoint": {"lat": 51.18539, "lon": 6.44172}}, {"city": "Homburg", "state": "Saarland", "zip": "66421", "country": "Germany", "geoPoint": {"lat": 49.32637, "lon": 7.33867}}, {"city": "Erfurt", "state": "Th\u00fcringen", "zip": "99089", "country": "Germany", "geoPoint": {"lat": 50.9787, "lon": 11.03283}}, {"city": "Berlin", "zip": "13353", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"city": "Athens", "zip": "11526", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"city": "Athens", "zip": "11527", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"city": "Chaidari", "zip": "12462", "country": "Greece", "geoPoint": {"lat": 38.01135, "lon": 23.66597}}, {"city": "Larissa", "zip": "41100", "country": "Greece", "geoPoint": {"lat": 39.63689, "lon": 22.41761}}, {"city": "Nea Ionia / Athens", "zip": "14233", "country": "Greece"}, {"city": "Budapest", "zip": "1027", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"city": "Budapest", "zip": "1085", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"city": "Budapest", "zip": "1097", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"city": "Nagykanizsa", "zip": "8800", "country": "Hungary", "geoPoint": {"lat": 46.45347, "lon": 16.99104}}, {"city": "Szekesfehervar", "zip": "8000", "country": "Hungary", "geoPoint": {"lat": 47.18995, "lon": 18.41034}}, {"city": "Afula", "zip": "1834111", "country": "Israel", "geoPoint": {"lat": 32.60907, "lon": 35.2892}}, {"city": "Ashkelon", "zip": "7830604", "country": "Israel", "geoPoint": {"lat": 31.66926, "lon": 34.57149}}, {"city": "Hadera", "zip": "3810101", "country": "Israel", "geoPoint": {"lat": 32.44192, "lon": 34.9039}}, {"city": "Haifa", "zip": "3436212", "country": "Israel", "geoPoint": {"lat": 32.81841, "lon": 34.9885}}, {"city": "Jerusalem", "zip": "9103102", "country": "Israel", "geoPoint": {"lat": 31.76904, "lon": 35.21633}}, {"city": "Kfar Saba", "zip": "4428164", "country": "Israel", "geoPoint": {"lat": 32.175, "lon": 34.90694}}, {"city": "Nahariya", "zip": "2210001", "country": "Israel", "geoPoint": {"lat": 33.00892, "lon": 35.09814}}, {"city": "Petach Tikva", "zip": "4941492", "country": "Israel", "geoPoint": {"lat": 32.08707, "lon": 34.88747}}, {"city": "Rehovot", "zip": "7610001", "country": "Israel", "geoPoint": {"lat": 31.89421, "lon": 34.81199}}, {"city": "Tel Aviv", "zip": "64239", "country": "Israel", "geoPoint": {"lat": 32.08088, "lon": 34.78057}}, {"city": "Zefat", "zip": "1311001", "country": "Israel", "geoPoint": {"lat": 32.96465, "lon": 35.496}}, {"city": "Zerifin", "zip": "7030000", "country": "Israel", "geoPoint": {"lat": 31.95857, "lon": 4.83723}}, {"city": "Roma", "state": "Lazio", "zip": "00163", "country": "Italy", "geoPoint": {"lat": 41.89193, "lon": 12.51133}}, {"city": "Bergamo", "state": "Lombardia", "zip": "24127", "country": "Italy", "geoPoint": {"lat": 45.69601, "lon": 9.66721}}, {"city": "Milano", "state": "Lombardia", "zip": "20149", "country": "Italy", "geoPoint": {"lat": 45.46427, "lon": 9.18951}}, {"city": "Monza Brianza", "state": "Lombardia", "zip": "20900", "country": "Italy"}, {"city": "Foggia", "state": "Puglia", "zip": "71100", "country": "Italy", "geoPoint": {"lat": 41.45845, "lon": 15.55188}}, {"city": "Arezzo", "state": "Toscana", "zip": "52040", "country": "Italy", "geoPoint": {"lat": 43.46276, "lon": 11.88068}}, {"city": "Pisa", "state": "Toscana", "zip": "56124", "country": "Italy", "geoPoint": {"lat": 43.70853, "lon": 10.4036}}, {"city": "Perugia", "state": "Umbria", "zip": "06129", "country": "Italy", "geoPoint": {"lat": 43.1122, "lon": 12.38878}}, {"city": "Wonju", "state": "Gang''weondo", "zip": "26426", "country": "Korea, Republic of", "geoPoint": {"lat": 37.35139, "lon": 127.94528}}, {"city": "Seoul", "zip": "03080", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"city": "Seoul", "zip": "03722", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"city": "Seoul", "zip": "05505", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"city": "Kaunas", "zip": "LT-44320", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"city": "Kaunas", "zip": "LT-47144", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"city": "Kaunas", "zip": "LT-50161", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"city": "Klaipeda", "zip": "92288", "country": "Lithuania", "geoPoint": {"lat": 55.70888, "lon": 21.14311}}, {"city": "Klaipeda", "zip": "LT-92288", "country": "Lithuania", "geoPoint": {"lat": 55.70888, "lon": 21.14311}}, {"city": "Vilnius", "zip": "LT-08661", "country": "Lithuania", "geoPoint": {"lat": 54.68916, "lon": 25.2798}}, {"city": "Amsterdam", "zip": "1061 AE", "country": "Netherlands", "geoPoint": {"lat": 52.37403, "lon": 4.88969}}, {"city": "Delft", "zip": "2625 AD", "country": "Netherlands", "geoPoint": {"lat": 52.00667, "lon": 4.35556}}, {"city": "Groningen", "zip": "9700 RB", "country": "Netherlands", "geoPoint": {"lat": 53.21917, "lon": 6.56667}}, {"city": "Groningen", "zip": "9728 NT", "country": "Netherlands", "geoPoint": {"lat": 53.21917, "lon": 6.56667}}, {"city": "Hoogeveen", "zip": "7909 AA", "country": "Netherlands", "geoPoint": {"lat": 52.7225, "lon": 6.47639}}, {"city": "Nijmegen", "zip": "6525 GA", "country": "Netherlands", "geoPoint": {"lat": 51.8425, "lon": 5.85278}}, {"city": "Rotterdam", "zip": "3045 PM", "country": "Netherlands", "geoPoint": {"lat": 51.9225, "lon": 4.47917}}, {"city": "Veldhoven", "zip": "5504 DB", "country": "Netherlands", "geoPoint": {"lat": 51.41833, "lon": 5.40278}}, {"city": "Zutphen", "zip": "7207 AE", "country": "Netherlands", "geoPoint": {"lat": 52.13833, "lon": 6.20139}}, {"city": "Stavanger", "zip": "4011", "country": "Norway", "geoPoint": {"lat": 58.97005, "lon": 5.73332}}, {"city": "Bialystok", "zip": "15-276", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"city": "Bydgoszcz", "zip": "85-681", "country": "Poland", "geoPoint": {"lat": 53.1235, "lon": 18.00762}}, {"city": "Gdansk", "zip": "80-952", "country": "Poland", "geoPoint": {"lat": 54.35205, "lon": 18.64637}}, {"city": "Katowice", "zip": "40-635", "country": "Poland", "geoPoint": {"lat": 50.25841, "lon": 19.02754}}, {"city": "Kielce", "zip": "25-736", "country": "Poland", "geoPoint": {"lat": 50.87033, "lon": 20.62752}}, {"city": "Krakow", "zip": "31-121", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"city": "Szczecin", "zip": "70-965", "country": "Poland", "geoPoint": {"lat": 53.42894, "lon": 14.55302}}, {"city": "Warszawa", "zip": "04-628", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"city": "Wroclaw", "zip": "50-981", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}, {"city": "Almada", "zip": "2801-951", "country": "Portugal", "geoPoint": {"lat": 38.67902, "lon": -9.1569}}, {"city": "Faro", "zip": "8000-386", "country": "Portugal", "geoPoint": {"lat": 37.01937, "lon": -7.93223}}, {"city": "Lisboa", "zip": "1449-005", "country": "Portugal", "geoPoint": {"lat": 38.71667, "lon": -9.13333}}, {"city": "Lisboa", "zip": "1500-650", "country": "Portugal", "geoPoint": {"lat": 38.71667, "lon": -9.13333}}, {"city": "Lisboa", "zip": "1649-035", "country": "Portugal", "geoPoint": {"lat": 38.71667, "lon": -9.13333}}, {"city": "Porto", "zip": "P-4200", "country": "Portugal", "geoPoint": {"lat": 41.14961, "lon": -8.61099}}, {"city": "Petoria", "state": "Gauteng", "country": "South Africa"}, {"city": "Isipingo Rail", "state": "Kwazulu-Natal", "zip": "4110", "country": "South Africa"}, {"city": "Merebank", "state": "Kwazulu-Natal", "zip": "4052", "country": "South Africa", "geoPoint": {"lat": -29.9517, "lon": 30.95627}}, {"city": "Tongaat", "state": "Kwazulu-Natal", "zip": "4400", "country": "South Africa", "geoPoint": {"lat": -29.57215, "lon": 31.11682}}, {"city": "Cape Town", "state": "Western Cape", "zip": "7500", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"city": "Kuils River", "state": "Western Cape", "zip": "7580", "country": "South Africa", "geoPoint": {"lat": -33.94208, "lon": 18.70663}}, {"city": "Pinelands", "state": "Western Cape", "zip": "7405", "country": "South Africa"}, {"city": "Somerset West", "state": "Western Cape", "zip": "7130", "country": "South Africa", "geoPoint": {"lat": -34.08401, "lon": 18.82113}}, {"city": "Worcester", "state": "Western Cape", "zip": "6850", "country": "South Africa", "geoPoint": {"lat": -33.64651, "lon": 19.44852}}, {"city": "Olot", "state": "Girona", "zip": "17800", "country": "Spain", "geoPoint": {"lat": 42.18096, "lon": 2.49012}}, {"city": "Majadahonda", "state": "Madrid", "zip": "28222", "country": "Spain", "geoPoint": {"lat": 40.47353, "lon": -3.87182}}, {"city": "El Palmar", "state": "Murcia", "zip": "30120", "country": "Spain", "geoPoint": {"lat": 37.93939, "lon": -1.16095}}, {"city": "Barcelona", "zip": "08003", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"city": "Barcelona", "zip": "08035", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"city": "Madrid", "zip": "28041", "country": "Spain", "geoPoint": {"lat": 40.4165, "lon": -3.70256}}, {"city": "Valencia", "zip": "46010", "country": "Spain", "geoPoint": {"lat": 39.46975, "lon": -0.37739}}, {"city": "Valencia", "zip": "46026", "country": "Spain", "geoPoint": {"lat": 39.46975, "lon": -0.37739}}, {"city": "Falun", "zip": "791 82", "country": "Sweden", "geoPoint": {"lat": 60.60357, "lon": 15.62597}}, {"city": "G\u00f6teborg", "zip": "416 85", "country": "Sweden", "geoPoint": {"lat": 57.70716, "lon": 11.96679}}, {"city": "Stockholm", "zip": "118 83", "country": "Sweden", "geoPoint": {"lat": 59.33258, "lon": 18.0649}}, {"city": "Stockholm", "zip": "141 86", "country": "Sweden", "geoPoint": {"lat": 59.33258, "lon": 18.0649}}, {"city": "Stockholm", "zip": "182 88", "country": "Sweden", "geoPoint": {"lat": 59.33258, "lon": 18.0649}}, {"city": "Ume\u00e5", "zip": "901 85", "country": "Sweden", "geoPoint": {"lat": 63.82842, "lon": 20.25972}}, {"city": "\u00d6rebro", "zip": "701 85", "country": "Sweden", "geoPoint": {"lat": 59.27412, "lon": 15.2066}}, {"city": "New Taipei City", "zip": "220", "country": "Taiwan", "geoPoint": {"lat": 25.01111, "lon": 121.44583}}, {"city": "Taipei", "zip": "10002", "country": "Taiwan", "geoPoint": {"lat": 25.04776, "lon": 121.53185}}, {"city": "Taipei", "zip": "11217", "country": "Taiwan", "geoPoint": {"lat": 25.04776, "lon": 121.53185}}, {"city": "Taipei", "country": "Taiwan", "geoPoint": {"lat": 25.04776, "lon": 121.53185}}, {"city": "Taizung", "zip": "402", "country": "Taiwan"}, {"city": "Ankara", "zip": "06100", "country": "Turkey", "geoPoint": {"lat": 39.91987, "lon": 32.85427}}, {"city": "Ankara", "zip": "06500", "country": "Turkey", "geoPoint": {"lat": 39.91987, "lon": 32.85427}}, {"city": "Ankara", "country": "Turkey", "geoPoint": {"lat": 39.91987, "lon": 32.85427}}, {"city": "Antalya", "zip": "07003", "country": "Turkey", "geoPoint": {"lat": 36.90812, "lon": 30.69556}}, {"city": "Izmir", "zip": "35100", "country": "Turkey", "geoPoint": {"lat": 38.41273, "lon": 27.13838}}]}, "referencesModule": {"references": [{"pmid": "27130705", "type": "RESULT", "citation": "Filippatos G, Anker SD, Bohm M, Gheorghiade M, Kober L, Krum H, Maggioni AP, Ponikowski P, Voors AA, Zannad F, Kim SY, Nowack C, Palombo G, Kolkhof P, Kimmeskamp-Kirschbaum N, Pieper A, Pitt B. A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease. Eur Heart J. 2016 Jul 14;37(27):2105-14. doi: 10.1093/eurheartj/ehw132. Epub 2016 Apr 29."}, {"pmid": "33107592", "type": "RESULT", "citation": "Chung EY, Ruospo M, Natale P, Bolignano D, Navaneethan SD, Palmer SC, Strippoli GF. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease. Cochrane Database Syst Rev. 2020 Oct 27;10(10):CD007004. doi: 10.1002/14651858.CD007004.pub4."}, {"pmid": "25678098", "type": "RESULT", "citation": "Pitt B, Anker SD, Bohm M, Gheorghiade M, Kober L, Krum H, Maggioni AP, Ponikowski P, Voors AA, Zannad F, Nowack C, Kim SY, Pieper A, Kimmeskamp-Kirschbaum N, Filippatos G. Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease. Eur J Heart Fail. 2015 Feb;17(2):224-32. doi: 10.1002/ejhf.218."}], "seeAlsoLinks": [{"label": "Click here to find results for studies related to Bayer Healthcare products.", "url": "http://clinicaltrials.bayer.com/"}, {"label": "Click here to find information about studies related to Bayer Healthcare products conducted in Europe.", "url": "http://www.clinicaltrialsregister.eu/"}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Out of 1286 screened participants, 1066 participants were randomized, 1055 participants received study treatment and were valid for safety analysis set.", "recruitmentDetails": "Study was conducted in 168 study centers in 25 countries worldwide, from 17 June 2013 (first participant first visit) to 09 December 2014 (last participant last visit).", "groups": [{"id": "FG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "FG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "FG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "FG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "FG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "FG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "224"}, {"groupId": "FG001", "numSubjects": "173"}, {"groupId": "FG002", "numSubjects": "165"}, {"groupId": "FG003", "numSubjects": "169"}, {"groupId": "FG004", "numSubjects": "170"}, {"groupId": "FG005", "numSubjects": "165"}]}, {"type": "Participants Received Study Treatment and Valid for Safety Analysis Set", "achievements": [{"groupId": "FG000", "numSubjects": "221"}, {"groupId": "FG001", "numSubjects": "172"}, {"groupId": "FG002", "numSubjects": "163"}, {"groupId": "FG003", "numSubjects": "167"}, {"groupId": "FG004", "numSubjects": "169"}, {"groupId": "FG005", "numSubjects": "163"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "144"}, {"groupId": "FG001", "numSubjects": "121"}, {"groupId": "FG002", "numSubjects": "122"}, {"groupId": "FG003", "numSubjects": "123"}, {"groupId": "FG004", "numSubjects": "134"}, {"groupId": "FG005", "numSubjects": "124"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "80"}, {"groupId": "FG001", "numSubjects": "52"}, {"groupId": "FG002", "numSubjects": "43"}, {"groupId": "FG003", "numSubjects": "46"}, {"groupId": "FG004", "numSubjects": "36"}, {"groupId": "FG005", "numSubjects": "41"}]}], "dropWithdraws": [{"type": "Progressive disease", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "9"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "2"}, {"groupId": "FG004", "numSubjects": "1"}, {"groupId": "FG005", "numSubjects": "6"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "33"}, {"groupId": "FG001", "numSubjects": "22"}, {"groupId": "FG002", "numSubjects": "26"}, {"groupId": "FG003", "numSubjects": "25"}, {"groupId": "FG004", "numSubjects": "18"}, {"groupId": "FG005", "numSubjects": "21"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "2"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "1"}]}, {"type": "Non-compliance", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}, {"type": "Logistical difficulties", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "1"}, {"groupId": "FG005", "numSubjects": "0"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "33"}, {"groupId": "FG001", "numSubjects": "15"}, {"groupId": "FG002", "numSubjects": "8"}, {"groupId": "FG003", "numSubjects": "14"}, {"groupId": "FG004", "numSubjects": "16"}, {"groupId": "FG005", "numSubjects": "13"}]}, {"type": "Sponsor decision", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Safety analysis set (SAF): all randomized participants who took at least one dose of study drug and with data after beginning of treatment.", "groups": [{"id": "BG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "BG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "BG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "BG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "BG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "BG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "BG006", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "221"}, {"groupId": "BG001", "value": "172"}, {"groupId": "BG002", "value": "163"}, {"groupId": "BG003", "value": "167"}, {"groupId": "BG004", "value": "169"}, {"groupId": "BG005", "value": "163"}, {"groupId": "BG006", "value": "1055"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "221"}, {"groupId": "BG001", "value": "172"}, {"groupId": "BG002", "value": "163"}, {"groupId": "BG003", "value": "167"}, {"groupId": "BG004", "value": "169"}, {"groupId": "BG005", "value": "163"}, {"groupId": "BG006", "value": "1055"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "72.38", "spread": "9.92"}, {"groupId": "BG001", "value": "72.53", "spread": "9.74"}, {"groupId": "BG002", "value": "71.81", "spread": "10.55"}, {"groupId": "BG003", "value": "69.27", "spread": "9.83"}, {"groupId": "BG004", "value": "71.27", "spread": "10.27"}, {"groupId": "BG005", "value": "69.2", "spread": "10.15"}, {"groupId": "BG006", "value": "71.15", "spread": "10.14"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "221"}, {"groupId": "BG001", "value": "172"}, {"groupId": "BG002", "value": "163"}, {"groupId": "BG003", "value": "167"}, {"groupId": "BG004", "value": "169"}, {"groupId": "BG005", "value": "163"}, {"groupId": "BG006", "value": "1055"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "51"}, {"groupId": "BG001", "value": "37"}, {"groupId": "BG002", "value": "37"}, {"groupId": "BG003", "value": "43"}, {"groupId": "BG004", "value": "41"}, {"groupId": "BG005", "value": "31"}, {"groupId": "BG006", "value": "240"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "170"}, {"groupId": "BG001", "value": "135"}, {"groupId": "BG002", "value": "126"}, {"groupId": "BG003", "value": "124"}, {"groupId": "BG004", "value": "128"}, {"groupId": "BG005", "value": "132"}, {"groupId": "BG006", "value": "815"}]}]}]}, {"title": "Baseline BNP", "description": "B-type natriuretic peptide (BNP) levels in the blood are used for screening, diagnosis of acute chronic heart failure (CHF) and may be useful to establish prognosis in heart failure.", "populationDescription": "Participants with valid data for this baseline characteristic", "paramType": "GEOMETRIC_MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "pg/ml", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "203"}, {"groupId": "BG001", "value": "156"}, {"groupId": "BG002", "value": "151"}, {"groupId": "BG003", "value": "156"}, {"groupId": "BG004", "value": "158"}, {"groupId": "BG005", "value": "155"}, {"groupId": "BG006", "value": "979"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "594.290", "spread": "2.601"}, {"groupId": "BG001", "value": "677.906", "spread": "2.637"}, {"groupId": "BG002", "value": "574.245", "spread": "2.543"}, {"groupId": "BG003", "value": "570.776", "spread": "2.741"}, {"groupId": "BG004", "value": "606.080", "spread": "2.598"}, {"groupId": "BG005", "value": "552.032", "spread": "2.698"}, {"groupId": "BG006", "value": "594.732", "spread": "2.634"}]}]}]}, {"title": "Baseline NT-proBNP", "description": "N-terminal pro-B type natriuretic peptide (NT-proBNP) levels in the blood are used for screening, diagnosis of acute chronic heart failure (CHF) and may be useful to establish prognosis in heart failure.", "populationDescription": "Participants with valid data for this baseline characteristic", "paramType": "GEOMETRIC_MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "pg/ml", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "207"}, {"groupId": "BG001", "value": "162"}, {"groupId": "BG002", "value": "157"}, {"groupId": "BG003", "value": "158"}, {"groupId": "BG004", "value": "160"}, {"groupId": "BG005", "value": "158"}, {"groupId": "BG006", "value": "1002"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "4730.170", "spread": "2.938"}, {"groupId": "BG001", "value": "4793.430", "spread": "3.084"}, {"groupId": "BG002", "value": "4184.631", "spread": "3.093"}, {"groupId": "BG003", "value": "3776.859", "spread": "3.395"}, {"groupId": "BG004", "value": "4163.898", "spread": "2.734"}, {"groupId": "BG005", "value": "3791.677", "spread": "3.013"}, {"groupId": "BG006", "value": "4246.883", "spread": "3.040"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Percentage of Participants With a Relative Decrease in NT-proBNP of More Than 30% From Baseline to Day 90", "description": "N-terminal pro-B type natriuretic peptide (NT-proBNP) levels in the blood are used for screening, diagnosis of acute and chronic heart failure (CHF) and may be useful to establish prognosis in heart failure.", "populationDescription": "Full analysis set (FAS): all participants who the study drug, had baseline and at least one post-baseline NT-proBNP value or who died or experienced permanent (\u22655 consecutive days) withdrawal of study drug after cardiovascular (CV) hospitalization or after emergency presentation for Worsening Chronic Heart Failure (WCHF)", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "90% Confidence Interval", "unitOfMeasure": "Percentage of participants", "timeFrame": "Baseline and Day 90", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "207"}, {"groupId": "OG001", "value": "162"}, {"groupId": "OG002", "value": "157"}, {"groupId": "OG003", "value": "158"}, {"groupId": "OG004", "value": "160"}, {"groupId": "OG005", "value": "158"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "37.2", "spread": "31.6", "lowerLimit": "31.6", "upperLimit": "43.1"}, {"groupId": "OG001", "value": "30.9", "spread": "24.9", "lowerLimit": "24.9", "upperLimit": "37.4"}, {"groupId": "OG002", "value": "32.5", "spread": "26.3", "lowerLimit": "26.3", "upperLimit": "39.2"}, {"groupId": "OG003", "value": "37.3", "spread": "30.9", "lowerLimit": "30.9", "upperLimit": "44.1"}, {"groupId": "OG004", "value": "38.8", "spread": "32.3", "lowerLimit": "32.3", "upperLimit": "45.5"}, {"groupId": "OG005", "value": "34.2", "spread": "27.9", "lowerLimit": "27.9", "upperLimit": "40.9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Estimates and two-sided 90% confidence intervals are provided for each treatment group and for the treatment differences \u03c0Bi - \u03c0C. Clopper-Pearson confidence intervals were calculated for each treatment group, while for treatment differences the exact unconditional confidence limits were calculated.", "nonInferiorityType": "OTHER", "pValue": "0.8771", "statisticalMethod": "Chi-squared", "paramType": "Mean Difference (Final Values)", "paramValue": "-6.3", "ciPctValue": "90", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-14.9", "ciUpperLimit": "2.3"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Estimates and two-sided 90% confidence intervals are provided for each treatment group and for the treatment differences \u03c0Bi - \u03c0C. Clopper-Pearson confidence intervals were calculated for each treatment group, while for treatment differences the exact unconditional confidence limits were calculated.", "nonInferiorityType": "OTHER", "pValue": "0.7945", "statisticalMethod": "Chi-squared", "paramType": "Mean Difference (Final Values)", "paramValue": "-4.7", "ciPctValue": "90", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-13.4", "ciUpperLimit": "4"}, {"groupIds": ["OG000", "OG003"], "groupDescription": "Estimates and two-sided 90% confidence intervals are provided for each treatment group and for the treatment differences \u03c0Bi - \u03c0C. Clopper-Pearsonconfidence intervals were calculated for each treatment group, while for treatment differences the exact unconditional confidence limits were calculated.", "nonInferiorityType": "OTHER", "pValue": "0.5", "statisticalMethod": "Chi-squared", "paramType": "Mean Difference (Final Values)", "paramValue": "0.1", "ciPctValue": "90", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-8.5", "ciUpperLimit": "8.8"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Estimates and two-sided 90% confidence intervals are provided for each treatment group and for the treatment differences \u03c0Bi - \u03c0C. Clopper-Pearsonconfidence intervals were calculated for each treatment group, while for treatment differences the exact unconditional confidence limits were calculated.", "nonInferiorityType": "OTHER", "pValue": "0.4225", "statisticalMethod": "Chi-squared", "paramType": "Mean Difference (Final Values)", "paramValue": "1.6", "ciPctValue": "90", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-7.1", "ciUpperLimit": "10.2"}, {"groupIds": ["OG000", "OG005"], "groupDescription": "Estimates and two-sided 90% confidence intervals are provided for each treatment group and for the treatment differences \u03c0Bi - \u03c0C. Clopper-Pearson confidence intervals were calculated for each treatment group, while for treatment differences the exact unconditional confidence limits were calculated.", "nonInferiorityType": "OTHER", "pValue": "0.6865", "statisticalMethod": "Chi-squared", "paramType": "Mean Difference (Final Values)", "paramValue": "-3", "ciPctValue": "90", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-11.7", "ciUpperLimit": "5.7"}]}, {"type": "SECONDARY", "title": "Number of Participants With Death Due to Any Cause", "description": "Death due to any cause include cardiovascular (CV) death and Non-CV death. Non-CV death was classified by 2 subcategories: non-malignant causes and malignant causes.", "populationDescription": "Participants in FAS", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Day 30, Day 60, Day 90 and Follow-up (30 days post-last dose, assessed up to Day 120)", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "207"}, {"groupId": "OG001", "value": "162"}, {"groupId": "OG002", "value": "157"}, {"groupId": "OG003", "value": "158"}, {"groupId": "OG004", "value": "160"}, {"groupId": "OG005", "value": "158"}]}], "classes": [{"title": "Day 30", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "5"}, {"groupId": "OG002", "value": "1"}, {"groupId": "OG003", "value": "1"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "2"}]}]}, {"title": "Day 60", "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "7"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "2"}, {"groupId": "OG004", "value": "0"}, {"groupId": "OG005", "value": "4"}]}]}, {"title": "Day 90", "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "10"}, {"groupId": "OG002", "value": "4"}, {"groupId": "OG003", "value": "4"}, {"groupId": "OG004", "value": "1"}, {"groupId": "OG005", "value": "5"}]}]}, {"title": "Follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "15"}, {"groupId": "OG001", "value": "16"}, {"groupId": "OG002", "value": "7"}, {"groupId": "OG003", "value": "11"}, {"groupId": "OG004", "value": "2"}, {"groupId": "OG005", "value": "8"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With Cardiovascular Hospitalization", "description": "Hospitalizations were defined as any unplanned admission to hospital, i.e. completion of hospital admission procedures and one overnight \\[i.e. date change\\] stay or until the death of subject occurred. Hospitalizations and deaths were classified by 2 primary categories: CV and non-CV. The pre-specified subcategories for CV hospitalizations were as follows: 1. Worsening heart failure, 2.Acute myocardial infarction, 3. Arrhythmia, 4.Transient ischemic attack and stroke, 5. Other CV hospitalizations.", "populationDescription": "Participants in FAS", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Day 30, Day 60, Day 90 and Follow-up (30 days post-last dose, assessed up to Day 120)", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "207"}, {"groupId": "OG001", "value": "162"}, {"groupId": "OG002", "value": "157"}, {"groupId": "OG003", "value": "158"}, {"groupId": "OG004", "value": "160"}, {"groupId": "OG005", "value": "158"}]}], "classes": [{"title": "Day 30", "categories": [{"measurements": [{"groupId": "OG000", "value": "28"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "14"}, {"groupId": "OG003", "value": "8"}, {"groupId": "OG004", "value": "7"}, {"groupId": "OG005", "value": "15"}]}]}, {"title": "Day 60", "categories": [{"measurements": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "33"}, {"groupId": "OG002", "value": "23"}, {"groupId": "OG003", "value": "21"}, {"groupId": "OG004", "value": "15"}, {"groupId": "OG005", "value": "23"}]}]}, {"title": "Day 90", "categories": [{"measurements": [{"groupId": "OG000", "value": "45"}, {"groupId": "OG001", "value": "35"}, {"groupId": "OG002", "value": "26"}, {"groupId": "OG003", "value": "29"}, {"groupId": "OG004", "value": "22"}, {"groupId": "OG005", "value": "28"}]}]}, {"title": "Follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "56"}, {"groupId": "OG001", "value": "43"}, {"groupId": "OG002", "value": "38"}, {"groupId": "OG003", "value": "36"}, {"groupId": "OG004", "value": "27"}, {"groupId": "OG005", "value": "34"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With Emergency Presentations for Worsening Chronic Heart Failure (WCHF)", "description": "Emergency presentations for WCHF were defined as newly developing signs and symptoms of WCHF after start of treatment with study drug, requiring an additional emergency presentation to hospital and IV treatment with diuretics and/or positive inotropic agents.", "populationDescription": "Participants in FAS", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Day 30, Day 60, Day 90 and Follow-up (30 days post-last dose, assessed up to Day 120)", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "207"}, {"groupId": "OG001", "value": "162"}, {"groupId": "OG002", "value": "157"}, {"groupId": "OG003", "value": "158"}, {"groupId": "OG004", "value": "160"}, {"groupId": "OG005", "value": "158"}]}], "classes": [{"title": "Day 30", "categories": [{"measurements": [{"groupId": "OG000", "value": "21"}, {"groupId": "OG001", "value": "19"}, {"groupId": "OG002", "value": "12"}, {"groupId": "OG003", "value": "9"}, {"groupId": "OG004", "value": "7"}, {"groupId": "OG005", "value": "15"}]}]}, {"title": "Day 60", "categories": [{"measurements": [{"groupId": "OG000", "value": "35"}, {"groupId": "OG001", "value": "30"}, {"groupId": "OG002", "value": "20"}, {"groupId": "OG003", "value": "17"}, {"groupId": "OG004", "value": "14"}, {"groupId": "OG005", "value": "22"}]}]}, {"title": "Day 90", "categories": [{"measurements": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "32"}, {"groupId": "OG002", "value": "22"}, {"groupId": "OG003", "value": "24"}, {"groupId": "OG004", "value": "18"}, {"groupId": "OG005", "value": "28"}]}]}, {"title": "Follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "47"}, {"groupId": "OG001", "value": "40"}, {"groupId": "OG002", "value": "30"}, {"groupId": "OG003", "value": "30"}, {"groupId": "OG004", "value": "26"}, {"groupId": "OG005", "value": "34"}]}]}]}, {"type": "SECONDARY", "title": "Ratio of BNP at Specified Visits to BNP at Baseline", "description": "B-type natriuretic peptide (BNP) levels in the blood are used for screening, diagnosis of acute chronic heart failure (CHF) and may be useful to establish prognosis in heart failure.", "populationDescription": "Participants in FAS with valid data at specified visits", "reportingStatus": "POSTED", "paramType": "GEOMETRIC_MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Ratio", "timeFrame": "Day 30, Day 60, Day 90, Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}, {"groupId": "OG001", "value": "156"}, {"groupId": "OG002", "value": "151"}, {"groupId": "OG003", "value": "156"}, {"groupId": "OG004", "value": "158"}, {"groupId": "OG005", "value": "155"}]}], "classes": [{"title": "Day 30", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "176"}, {"groupId": "OG001", "value": "136"}, {"groupId": "OG002", "value": "136"}, {"groupId": "OG003", "value": "141"}, {"groupId": "OG004", "value": "139"}, {"groupId": "OG005", "value": "133"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.925", "spread": "2.02"}, {"groupId": "OG001", "value": "0.944", "spread": "1.952"}, {"groupId": "OG002", "value": "0.878", "spread": "1.713"}, {"groupId": "OG003", "value": "0.832", "spread": "1.959"}, {"groupId": "OG004", "value": "0.852", "spread": "1.901"}, {"groupId": "OG005", "value": "0.879", "spread": "1.968"}]}]}, {"title": "Day 60", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "148"}, {"groupId": "OG001", "value": "130"}, {"groupId": "OG002", "value": "128"}, {"groupId": "OG003", "value": "125"}, {"groupId": "OG004", "value": "133"}, {"groupId": "OG005", "value": "128"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.783", "spread": "2.194"}, {"groupId": "OG001", "value": "0.864", "spread": "2.139"}, {"groupId": "OG002", "value": "0.854", "spread": "1.854"}, {"groupId": "OG003", "value": "0.79", "spread": "2.179"}, {"groupId": "OG004", "value": "0.711", "spread": "2.116"}, {"groupId": "OG005", "value": "0.824", "spread": "2.142"}]}]}, {"title": "Day 90", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "141"}, {"groupId": "OG001", "value": "119"}, {"groupId": "OG002", "value": "122"}, {"groupId": "OG003", "value": "119"}, {"groupId": "OG004", "value": "127"}, {"groupId": "OG005", "value": "120"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.723", "spread": "2.202"}, {"groupId": "OG001", "value": "0.813", "spread": "2.412"}, {"groupId": "OG002", "value": "0.839", "spread": "1.93"}, {"groupId": "OG003", "value": "0.719", "spread": "2.204"}, {"groupId": "OG004", "value": "0.706", "spread": "2.34"}, {"groupId": "OG005", "value": "0.771", "spread": "2.197"}]}]}, {"title": "Premature discontinuation", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "22"}, {"groupId": "OG003", "value": "19"}, {"groupId": "OG004", "value": "21"}, {"groupId": "OG005", "value": "22"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.896", "spread": "0.896"}, {"groupId": "OG001", "value": "1.104", "spread": "2.15"}, {"groupId": "OG002", "value": "1.006", "spread": "2.422"}, {"groupId": "OG003", "value": "0.884", "spread": "1.973"}, {"groupId": "OG004", "value": "0.848", "spread": "2.218"}, {"groupId": "OG005", "value": "1.044", "spread": "2.174"}]}]}, {"title": "Follow-up", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "165"}, {"groupId": "OG001", "value": "128"}, {"groupId": "OG002", "value": "136"}, {"groupId": "OG003", "value": "126"}, {"groupId": "OG004", "value": "143"}, {"groupId": "OG005", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.795", "spread": "2.232"}, {"groupId": "OG001", "value": "0.815", "spread": "2.388"}, {"groupId": "OG002", "value": "0.886", "spread": "2.199"}, {"groupId": "OG003", "value": "0.726", "spread": "2.397"}, {"groupId": "OG004", "value": "0.729", "spread": "2.487"}, {"groupId": "OG005", "value": "0.852", "spread": "2.169"}]}]}]}, {"type": "SECONDARY", "title": "Ratio of NT-proBNP at Specified Visits to NT-proBNP at Baseline", "description": "N-terminal pro-B type natriuretic peptide (NT-proBNP) levels in the blood are used for screening, diagnosis of acute chronic heart failure (CHF) and may be useful to establish prognosis in heart failure.", "populationDescription": "Participants in FAS with valid data at specified visits", "reportingStatus": "POSTED", "paramType": "GEOMETRIC_MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Ratio", "timeFrame": "Day 30, Day 60, Day 90, Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "207"}, {"groupId": "OG001", "value": "162"}, {"groupId": "OG002", "value": "157"}, {"groupId": "OG003", "value": "158"}, {"groupId": "OG004", "value": "160"}, {"groupId": "OG005", "value": "158"}]}], "classes": [{"title": "Day 30", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "177"}, {"groupId": "OG001", "value": "137"}, {"groupId": "OG002", "value": "139"}, {"groupId": "OG003", "value": "145"}, {"groupId": "OG004", "value": "141"}, {"groupId": "OG005", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.883", "spread": "2.458"}, {"groupId": "OG001", "value": "0.98", "spread": "2.158"}, {"groupId": "OG002", "value": "0.874", "spread": "2.14"}, {"groupId": "OG003", "value": "0.888", "spread": "2.123"}, {"groupId": "OG004", "value": "0.822", "spread": "2.217"}, {"groupId": "OG005", "value": "0.921", "spread": "2.136"}]}]}, {"title": "Day 60", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "153"}, {"groupId": "OG001", "value": "131"}, {"groupId": "OG002", "value": "127"}, {"groupId": "OG003", "value": "125"}, {"groupId": "OG004", "value": "137"}, {"groupId": "OG005", "value": "130"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.749", "spread": "2.73"}, {"groupId": "OG001", "value": "0.822", "spread": "2.423"}, {"groupId": "OG002", "value": "0.814", "spread": "2.178"}, {"groupId": "OG003", "value": "0.81", "spread": "2.268"}, {"groupId": "OG004", "value": "0.748", "spread": "2.496"}, {"groupId": "OG005", "value": "0.829", "spread": "2.288"}]}]}, {"title": "Day 90", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "142"}, {"groupId": "OG001", "value": "119"}, {"groupId": "OG002", "value": "120"}, {"groupId": "OG003", "value": "118"}, {"groupId": "OG004", "value": "129"}, {"groupId": "OG005", "value": "121"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.688", "spread": "2.59"}, {"groupId": "OG001", "value": "0.789", "spread": "2.661"}, {"groupId": "OG002", "value": "0.765", "spread": "2.214"}, {"groupId": "OG003", "value": "0.783", "spread": "2.454"}, {"groupId": "OG004", "value": "0.728", "spread": "2.795"}, {"groupId": "OG005", "value": "0.771", "spread": "2.471"}]}]}, {"title": "Premature discontinuation", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "36"}, {"groupId": "OG001", "value": "23"}, {"groupId": "OG002", "value": "24"}, {"groupId": "OG003", "value": "21"}, {"groupId": "OG004", "value": "22"}, {"groupId": "OG005", "value": "25"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.948", "spread": "2.684"}, {"groupId": "OG001", "value": "1.369", "spread": "2.087"}, {"groupId": "OG002", "value": "1.267", "spread": "2.261"}, {"groupId": "OG003", "value": "0.927", "spread": "1.864"}, {"groupId": "OG004", "value": "1.133", "spread": "2.981"}, {"groupId": "OG005", "value": "0.965", "spread": "2.352"}]}]}, {"title": "Follow-up", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "165"}, {"groupId": "OG001", "value": "130"}, {"groupId": "OG002", "value": "139"}, {"groupId": "OG003", "value": "131"}, {"groupId": "OG004", "value": "144"}, {"groupId": "OG005", "value": "137"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.747", "spread": "2.616"}, {"groupId": "OG001", "value": "0.747", "spread": "2.741"}, {"groupId": "OG002", "value": "0.887", "spread": "2.604"}, {"groupId": "OG003", "value": "0.809", "spread": "2.647"}, {"groupId": "OG004", "value": "0.746", "spread": "2.472"}, {"groupId": "OG005", "value": "0.849", "spread": "2.348"}]}]}]}, {"type": "SECONDARY", "title": "Change From Baseline in KCCQ Questionnaire Scores at Specified Visits", "description": "The Kansas City Cardiomyopathy Questionnaire (KCCQ) was the leading health related quality of life measure for subjects with CHF. KCCQ was a 23 item questionnaire that independently measures the impact of subjects HF, or its treatment, on 7 distinct domains: self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. KCCQ clinical summary score is a composite assessment of physical limitations and total symptom scores. Results from the total symptom summary score are presented. Scores are transformed to a range of 0-100, in which higher scores reflect better health status. In the below table, categorical data represents change from baseline data at respective time points.", "populationDescription": "Participants in FAS with valid data at specified visits", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Scores on a scale", "timeFrame": "Baseline, Day 30 and Day 90", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}, {"groupId": "OG001", "value": "161"}, {"groupId": "OG002", "value": "156"}, {"groupId": "OG003", "value": "158"}, {"groupId": "OG004", "value": "160"}, {"groupId": "OG005", "value": "157"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}, {"groupId": "OG001", "value": "161"}, {"groupId": "OG002", "value": "156"}, {"groupId": "OG003", "value": "158"}, {"groupId": "OG004", "value": "160"}, {"groupId": "OG005", "value": "157"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "43.7", "spread": "23"}, {"groupId": "OG001", "value": "42.8", "spread": "22.6"}, {"groupId": "OG002", "value": "45.4", "spread": "24"}, {"groupId": "OG003", "value": "42.1", "spread": "23.2"}, {"groupId": "OG004", "value": "42.3", "spread": "23.7"}, {"groupId": "OG005", "value": "43.2", "spread": "22.5"}]}]}, {"title": "Day 30", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "177"}, {"groupId": "OG001", "value": "141"}, {"groupId": "OG002", "value": "137"}, {"groupId": "OG003", "value": "145"}, {"groupId": "OG004", "value": "141"}, {"groupId": "OG005", "value": "141"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "20.5", "spread": "26.2"}, {"groupId": "OG001", "value": "18.2", "spread": "22.7"}, {"groupId": "OG002", "value": "19.3", "spread": "26.5"}, {"groupId": "OG003", "value": "23", "spread": "24.4"}, {"groupId": "OG004", "value": "24.9", "spread": "22.9"}, {"groupId": "OG005", "value": "20.6", "spread": "27"}]}]}, {"title": "Day 90", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "141"}, {"groupId": "OG001", "value": "118"}, {"groupId": "OG002", "value": "121"}, {"groupId": "OG003", "value": "118"}, {"groupId": "OG004", "value": "129"}, {"groupId": "OG005", "value": "119"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "24.3", "spread": "27.6"}, {"groupId": "OG001", "value": "21.3", "spread": "27.2"}, {"groupId": "OG002", "value": "24.5", "spread": "27"}, {"groupId": "OG003", "value": "29.3", "spread": "28.6"}, {"groupId": "OG004", "value": "28.3", "spread": "23.8"}, {"groupId": "OG005", "value": "22.2", "spread": "30.6"}]}]}]}, {"type": "SECONDARY", "title": "Change From Baseline in EQ-5D-3L Questionnaire Scores at Specified Visits", "description": "EuroQol Group 5-Dimension, 3-Level (EQ-5D-3L): participant rated questionnaire to assess health-related quality of life. It consists of EQ-5D descriptive system and EQ-5D Visual Analog Scale (VAS). EQ-5D-3L descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems (1), some problems (2), and extreme problems (3). For this population, the possible EQ-5D-3L index scores ranges from -0.11 (that is, 3 for all 5 dimensions) to 1.0 (that is, 1 for all 5 dimensions), where higher scores indicate a better health state.", "populationDescription": "Participants in FAS with valid data at specified visits", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Scores on scale", "timeFrame": "Baseline, Day 30, Day 90, Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "207"}, {"groupId": "OG001", "value": "162"}, {"groupId": "OG002", "value": "157"}, {"groupId": "OG003", "value": "158"}, {"groupId": "OG004", "value": "160"}, {"groupId": "OG005", "value": "158"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "201"}, {"groupId": "OG001", "value": "160"}, {"groupId": "OG002", "value": "156"}, {"groupId": "OG003", "value": "157"}, {"groupId": "OG004", "value": "158"}, {"groupId": "OG005", "value": "158"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.58", "spread": "0.25"}, {"groupId": "OG001", "value": "0.59", "spread": "0.25"}, {"groupId": "OG002", "value": "0.62", "spread": "0.23"}, {"groupId": "OG003", "value": "0.58", "spread": "0.23"}, {"groupId": "OG004", "value": "0.56", "spread": "0.25"}, {"groupId": "OG005", "value": "0.59", "spread": "0.24"}]}]}, {"title": "Day 30", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "173"}, {"groupId": "OG001", "value": "141"}, {"groupId": "OG002", "value": "137"}, {"groupId": "OG003", "value": "143"}, {"groupId": "OG004", "value": "139"}, {"groupId": "OG005", "value": "135"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.23"}, {"groupId": "OG001", "value": "0.02", "spread": "0.24"}, {"groupId": "OG002", "value": "0.02", "spread": "0.23"}, {"groupId": "OG003", "value": "0.07", "spread": "0.22"}, {"groupId": "OG004", "value": "0.06", "spread": "0.23"}, {"groupId": "OG005", "value": "0.02", "spread": "0.25"}]}]}, {"title": "Day 90", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "139"}, {"groupId": "OG001", "value": "117"}, {"groupId": "OG002", "value": "122"}, {"groupId": "OG003", "value": "117"}, {"groupId": "OG004", "value": "126"}, {"groupId": "OG005", "value": "120"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08", "spread": "0.24"}, {"groupId": "OG001", "value": "0.03", "spread": "0.27"}, {"groupId": "OG002", "value": "0.04", "spread": "0.25"}, {"groupId": "OG003", "value": "0.08", "spread": "0.2"}, {"groupId": "OG004", "value": "0.1", "spread": "0.24"}, {"groupId": "OG005", "value": "0.06", "spread": "0.28"}]}]}, {"title": "Premature discontinuation", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "20"}, {"groupId": "OG002", "value": "19"}, {"groupId": "OG003", "value": "21"}, {"groupId": "OG004", "value": "17"}, {"groupId": "OG005", "value": "23"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.12", "spread": "0.25"}, {"groupId": "OG001", "value": "-0.06", "spread": "0.29"}, {"groupId": "OG002", "value": "-0.09", "spread": "0.24"}, {"groupId": "OG003", "value": "-0.1", "spread": "0.24"}, {"groupId": "OG004", "value": "-0.05", "spread": "0.25"}, {"groupId": "OG005", "value": "0", "spread": "0.29"}]}]}, {"title": "Follow-up", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "161"}, {"groupId": "OG001", "value": "129"}, {"groupId": "OG002", "value": "136"}, {"groupId": "OG003", "value": "133"}, {"groupId": "OG004", "value": "144"}, {"groupId": "OG005", "value": "139"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.06", "spread": "0.26"}, {"groupId": "OG001", "value": "0.01", "spread": "0.25"}, {"groupId": "OG002", "value": "0.01", "spread": "0.27"}, {"groupId": "OG003", "value": "0.08", "spread": "0.23"}, {"groupId": "OG004", "value": "0.07", "spread": "0.23"}, {"groupId": "OG005", "value": "0.04", "spread": "0.28"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change From Baseline in Serum Potassium at Specified Visits", "populationDescription": "Participants in SAF with valid data at specified visits", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "millimoles per liter (mmol/L)", "timeFrame": "Baseline, Day 30, Day 60, Day 90 and Follow-up (30 days post-last dose, assessed up to Day 120)", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "221"}, {"groupId": "OG001", "value": "172"}, {"groupId": "OG002", "value": "162"}, {"groupId": "OG003", "value": "167"}, {"groupId": "OG004", "value": "168"}, {"groupId": "OG005", "value": "163"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "221"}, {"groupId": "OG001", "value": "172"}, {"groupId": "OG002", "value": "162"}, {"groupId": "OG003", "value": "167"}, {"groupId": "OG004", "value": "168"}, {"groupId": "OG005", "value": "163"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "4.159", "spread": "0.495"}, {"groupId": "OG001", "value": "4.081", "spread": "0.501"}, {"groupId": "OG002", "value": "4.211", "spread": "0.541"}, {"groupId": "OG003", "value": "4.174", "spread": "0.443"}, {"groupId": "OG004", "value": "4.131", "spread": "0.506"}, {"groupId": "OG005", "value": "4.117", "spread": "0.506"}]}]}, {"title": "Day 30", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "178"}, {"groupId": "OG001", "value": "136"}, {"groupId": "OG002", "value": "137"}, {"groupId": "OG003", "value": "142"}, {"groupId": "OG004", "value": "143"}, {"groupId": "OG005", "value": "137"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.057", "spread": "0.608"}, {"groupId": "OG001", "value": "0.135", "spread": "0.573"}, {"groupId": "OG002", "value": "0.075", "spread": "0.523"}, {"groupId": "OG003", "value": "0.085", "spread": "0.475"}, {"groupId": "OG004", "value": "0.21", "spread": "0.592"}, {"groupId": "OG005", "value": "0.193", "spread": "0.556"}]}]}, {"title": "Day 60", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "151"}, {"groupId": "OG001", "value": "130"}, {"groupId": "OG002", "value": "125"}, {"groupId": "OG003", "value": "129"}, {"groupId": "OG004", "value": "134"}, {"groupId": "OG005", "value": "129"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.179", "spread": "0.589"}, {"groupId": "OG001", "value": "0.091", "spread": "0.568"}, {"groupId": "OG002", "value": "0.131", "spread": "0.566"}, {"groupId": "OG003", "value": "0.171", "spread": "0.54"}, {"groupId": "OG004", "value": "0.274", "spread": "0.522"}, {"groupId": "OG005", "value": "0.216", "spread": "0.547"}]}]}, {"title": "Day 90", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "143"}, {"groupId": "OG001", "value": "117"}, {"groupId": "OG002", "value": "118"}, {"groupId": "OG003", "value": "121"}, {"groupId": "OG004", "value": "128"}, {"groupId": "OG005", "value": "119"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.307", "spread": "0.609"}, {"groupId": "OG001", "value": "0.184", "spread": "0.574"}, {"groupId": "OG002", "value": "0.153", "spread": "0.516"}, {"groupId": "OG003", "value": "0.164", "spread": "0.579"}, {"groupId": "OG004", "value": "0.275", "spread": "0.58"}, {"groupId": "OG005", "value": "0.245", "spread": "0.574"}]}]}, {"title": "Follow-up", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "164"}, {"groupId": "OG001", "value": "131"}, {"groupId": "OG002", "value": "139"}, {"groupId": "OG003", "value": "134"}, {"groupId": "OG004", "value": "145"}, {"groupId": "OG005", "value": "137"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.117", "spread": "0.621"}, {"groupId": "OG001", "value": "0.226", "spread": "0.694"}, {"groupId": "OG002", "value": "0.054", "spread": "0.623"}, {"groupId": "OG003", "value": "0.05", "spread": "0.572"}, {"groupId": "OG004", "value": "0.175", "spread": "0.559"}, {"groupId": "OG005", "value": "0.036", "spread": "0.556"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change From Baseline in Systolic Blood Pressure at Specified Visits", "populationDescription": "Participants in SAF with valid data at specified visits", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "millimeter of mercury (mmHg)", "timeFrame": "Baseline,Day 7,14,30,60,90,Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "218"}, {"groupId": "OG001", "value": "171"}, {"groupId": "OG002", "value": "160"}, {"groupId": "OG003", "value": "165"}, {"groupId": "OG004", "value": "169"}, {"groupId": "OG005", "value": "163"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "218"}, {"groupId": "OG001", "value": "171"}, {"groupId": "OG002", "value": "160"}, {"groupId": "OG003", "value": "165"}, {"groupId": "OG004", "value": "169"}, {"groupId": "OG005", "value": "163"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "120.554", "spread": "18.706"}, {"groupId": "OG001", "value": "119.492", "spread": "16.348"}, {"groupId": "OG002", "value": "118.498", "spread": "14.355"}, {"groupId": "OG003", "value": "119.087", "spread": "16.677"}, {"groupId": "OG004", "value": "116.024", "spread": "16.895"}, {"groupId": "OG005", "value": "116.941", "spread": "16.548"}]}]}, {"title": "Day 7", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "204"}, {"groupId": "OG001", "value": "158"}, {"groupId": "OG002", "value": "154"}, {"groupId": "OG003", "value": "158"}, {"groupId": "OG004", "value": "163"}, {"groupId": "OG005", "value": "157"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.541", "spread": "13.894"}, {"groupId": "OG001", "value": "-3.178", "spread": "13.72"}, {"groupId": "OG002", "value": "-2.565", "spread": "12.278"}, {"groupId": "OG003", "value": "0.568", "spread": "12.733"}, {"groupId": "OG004", "value": "0.162", "spread": "15.416"}, {"groupId": "OG005", "value": "-0.546", "spread": "13.498"}]}]}, {"title": "Day 14", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "49"}, {"groupId": "OG001", "value": "27"}, {"groupId": "OG002", "value": "40"}, {"groupId": "OG003", "value": "36"}, {"groupId": "OG004", "value": "37"}, {"groupId": "OG005", "value": "32"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.442", "spread": "14.258"}, {"groupId": "OG001", "value": "-4.488", "spread": "10.31"}, {"groupId": "OG002", "value": "4.142", "spread": "15.001"}, {"groupId": "OG003", "value": "1.241", "spread": "13.561"}, {"groupId": "OG004", "value": "-3.099", "spread": "12.591"}, {"groupId": "OG005", "value": "-2.906", "spread": "15.406"}]}]}, {"title": "Day 30", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "177"}, {"groupId": "OG001", "value": "143"}, {"groupId": "OG002", "value": "138"}, {"groupId": "OG003", "value": "147"}, {"groupId": "OG004", "value": "145"}, {"groupId": "OG005", "value": "139"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.067", "spread": "15.312"}, {"groupId": "OG001", "value": "-0.824", "spread": "15.747"}, {"groupId": "OG002", "value": "-0.367", "spread": "14.984"}, {"groupId": "OG003", "value": "0.374", "spread": "14.433"}, {"groupId": "OG004", "value": "1.786", "spread": "15.039"}, {"groupId": "OG005", "value": "0.899", "spread": "14.608"}]}]}, {"title": "Day 60", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "155"}, {"groupId": "OG001", "value": "128"}, {"groupId": "OG002", "value": "130"}, {"groupId": "OG003", "value": "129"}, {"groupId": "OG004", "value": "139"}, {"groupId": "OG005", "value": "131"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.684", "spread": "16.315"}, {"groupId": "OG001", "value": "0.337", "spread": "14.176"}, {"groupId": "OG002", "value": "-1.249", "spread": "13.659"}, {"groupId": "OG003", "value": "-1.811", "spread": "14.462"}, {"groupId": "OG004", "value": "0.981", "spread": "15.525"}, {"groupId": "OG005", "value": "0.667", "spread": "14.83"}]}]}, {"title": "Day 90", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "141"}, {"groupId": "OG001", "value": "119"}, {"groupId": "OG002", "value": "121"}, {"groupId": "OG003", "value": "121"}, {"groupId": "OG004", "value": "131"}, {"groupId": "OG005", "value": "122"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.967", "spread": "16.408"}, {"groupId": "OG001", "value": "0.922", "spread": "15.847"}, {"groupId": "OG002", "value": "0.047", "spread": "15.643"}, {"groupId": "OG003", "value": "-0.664", "spread": "15.018"}, {"groupId": "OG004", "value": "1.216", "spread": "17.831"}, {"groupId": "OG005", "value": "0.956", "spread": "15.743"}]}]}, {"title": "Premature discontinuation", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "37"}, {"groupId": "OG001", "value": "24"}, {"groupId": "OG002", "value": "24"}, {"groupId": "OG003", "value": "23"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "24"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.991", "spread": "16.456"}, {"groupId": "OG001", "value": "-0.41", "spread": "13.936"}, {"groupId": "OG002", "value": "-2.167", "spread": "19.963"}, {"groupId": "OG003", "value": "9.391", "spread": "22.378"}, {"groupId": "OG004", "value": "-2.32", "spread": "11.963"}, {"groupId": "OG005", "value": "-0.028", "spread": "15.42"}]}]}, {"title": "Follow-up", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "165"}, {"groupId": "OG001", "value": "131"}, {"groupId": "OG002", "value": "141"}, {"groupId": "OG003", "value": "135"}, {"groupId": "OG004", "value": "153"}, {"groupId": "OG005", "value": "143"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.188", "spread": "16.751"}, {"groupId": "OG001", "value": "2.869", "spread": "15.502"}, {"groupId": "OG002", "value": "1.95", "spread": "16.148"}, {"groupId": "OG003", "value": "-0.928", "spread": "17.953"}, {"groupId": "OG004", "value": "2.041", "spread": "16.189"}, {"groupId": "OG005", "value": "3.037", "spread": "16.782"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change From Baseline in Diastolic Blood Pressure at Specified Visits", "populationDescription": "Participants in SAF with valid data at specified visits", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "millimeter for mercury (mmHg)", "timeFrame": "Baseline,Day 7,14,30,60,90,Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "218"}, {"groupId": "OG001", "value": "171"}, {"groupId": "OG002", "value": "160"}, {"groupId": "OG003", "value": "165"}, {"groupId": "OG004", "value": "169"}, {"groupId": "OG005", "value": "163"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "218"}, {"groupId": "OG001", "value": "171"}, {"groupId": "OG002", "value": "160"}, {"groupId": "OG003", "value": "165"}, {"groupId": "OG004", "value": "169"}, {"groupId": "OG005", "value": "163"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "71.633", "spread": "11.647"}, {"groupId": "OG001", "value": "71.044", "spread": "10.762"}, {"groupId": "OG002", "value": "71.442", "spread": "8.508"}, {"groupId": "OG003", "value": "70.61", "spread": "9.692"}, {"groupId": "OG004", "value": "70.343", "spread": "10.394"}, {"groupId": "OG005", "value": "71.145", "spread": "9.809"}]}]}, {"title": "Day 7", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "204"}, {"groupId": "OG001", "value": "158"}, {"groupId": "OG002", "value": "154"}, {"groupId": "OG003", "value": "158"}, {"groupId": "OG004", "value": "163"}, {"groupId": "OG005", "value": "157"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.351", "spread": "10.237"}, {"groupId": "OG001", "value": "-1.693", "spread": "9.911"}, {"groupId": "OG002", "value": "-2.143", "spread": "9.848"}, {"groupId": "OG003", "value": "0.013", "spread": "9.733"}, {"groupId": "OG004", "value": "-0.738", "spread": "10.534"}, {"groupId": "OG005", "value": "-1.166", "spread": "8.964"}]}]}, {"title": "Day 14", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "49"}, {"groupId": "OG001", "value": "27"}, {"groupId": "OG002", "value": "40"}, {"groupId": "OG003", "value": "36"}, {"groupId": "OG004", "value": "37"}, {"groupId": "OG005", "value": "32"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.442", "spread": "10.089"}, {"groupId": "OG001", "value": "-0.537", "spread": "9.59"}, {"groupId": "OG002", "value": "1.608", "spread": "9.423"}, {"groupId": "OG003", "value": "-0.083", "spread": "7.421"}, {"groupId": "OG004", "value": "-2.387", "spread": "10.51"}, {"groupId": "OG005", "value": "-0.625", "spread": "9.41"}]}]}, {"title": "Day 30", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "177"}, {"groupId": "OG001", "value": "143"}, {"groupId": "OG002", "value": "138"}, {"groupId": "OG003", "value": "147"}, {"groupId": "OG004", "value": "145"}, {"groupId": "OG005", "value": "139"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.503", "spread": "10.826"}, {"groupId": "OG001", "value": "0.146", "spread": "10.667"}, {"groupId": "OG002", "value": "-0.845", "spread": "8.91"}, {"groupId": "OG003", "value": "-0.068", "spread": "9.633"}, {"groupId": "OG004", "value": "-0.094", "spread": "10.086"}, {"groupId": "OG005", "value": "-1.163", "spread": "9.622"}]}]}, {"title": "Day 60", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "155"}, {"groupId": "OG001", "value": "128"}, {"groupId": "OG002", "value": "130"}, {"groupId": "OG003", "value": "129"}, {"groupId": "OG004", "value": "139"}, {"groupId": "OG005", "value": "131"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.613", "spread": "11.096"}, {"groupId": "OG001", "value": "-0.199", "spread": "11.297"}, {"groupId": "OG002", "value": "-2.144", "spread": "9.552"}, {"groupId": "OG003", "value": "-0.85", "spread": "10.472"}, {"groupId": "OG004", "value": "0.17", "spread": "10.312"}, {"groupId": "OG005", "value": "-0.575", "spread": "10.427"}]}]}, {"title": "Day 90", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "141"}, {"groupId": "OG001", "value": "119"}, {"groupId": "OG002", "value": "121"}, {"groupId": "OG003", "value": "121"}, {"groupId": "OG004", "value": "131"}, {"groupId": "OG005", "value": "122"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.716", "spread": "11.035"}, {"groupId": "OG001", "value": "-0.106", "spread": "11.148"}, {"groupId": "OG002", "value": "-1.738", "spread": "9.015"}, {"groupId": "OG003", "value": "-1.121", "spread": "9.96"}, {"groupId": "OG004", "value": "-0.545", "spread": "11.212"}, {"groupId": "OG005", "value": "-0.877", "spread": "11.327"}]}]}, {"title": "Premature discontinuation", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "36"}, {"groupId": "OG001", "value": "24"}, {"groupId": "OG002", "value": "24"}, {"groupId": "OG003", "value": "23"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "24"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.185", "spread": "11.853"}, {"groupId": "OG001", "value": "0.868", "spread": "9.239"}, {"groupId": "OG002", "value": "-2.194", "spread": "15.522"}, {"groupId": "OG003", "value": "4.101", "spread": "12.151"}, {"groupId": "OG004", "value": "-2.96", "spread": "9.199"}, {"groupId": "OG005", "value": "-0.083", "spread": "10.113"}]}]}, {"title": "Follow-up", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "165"}, {"groupId": "OG001", "value": "131"}, {"groupId": "OG002", "value": "141"}, {"groupId": "OG003", "value": "135"}, {"groupId": "OG004", "value": "153"}, {"groupId": "OG005", "value": "143"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.218", "spread": "11.477"}, {"groupId": "OG001", "value": "0.696", "spread": "13.172"}, {"groupId": "OG002", "value": "-0.444", "spread": "10.197"}, {"groupId": "OG003", "value": "-1.16", "spread": "11.114"}, {"groupId": "OG004", "value": "-0.298", "spread": "11.521"}, {"groupId": "OG005", "value": "-0.172", "spread": "10.211"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change From Baseline in Heart Rate at Specified Visits", "populationDescription": "Participants in SAF with valid data at specified visits", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Beats per minute (Beats/min)", "timeFrame": "Baseline,Day 7,14,30,60,90,Premature discontinuation (only for participants who have discontinued the study prematurely, to be performed as soon as possible after withdrawal of study drug) and Follow-up (30 days post-last dose, assessed up to Day 120)", "groups": [{"id": "OG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days."}, {"id": "OG001", "title": "Finerenone (BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}, {"id": "OG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "217"}, {"groupId": "OG001", "value": "171"}, {"groupId": "OG002", "value": "160"}, {"groupId": "OG003", "value": "165"}, {"groupId": "OG004", "value": "169"}, {"groupId": "OG005", "value": "162"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "217"}, {"groupId": "OG001", "value": "171"}, {"groupId": "OG002", "value": "160"}, {"groupId": "OG003", "value": "165"}, {"groupId": "OG004", "value": "169"}, {"groupId": "OG005", "value": "162"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "74.957", "spread": "13.813"}, {"groupId": "OG001", "value": "73.369", "spread": "13.396"}, {"groupId": "OG002", "value": "72.681", "spread": "12.623"}, {"groupId": "OG003", "value": "74.184", "spread": "12.369"}, {"groupId": "OG004", "value": "73.852", "spread": "11.999"}, {"groupId": "OG005", "value": "74.329", "spread": "13.187"}]}]}, {"title": "Day 7", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "203"}, {"groupId": "OG001", "value": "158"}, {"groupId": "OG002", "value": "153"}, {"groupId": "OG003", "value": "158"}, {"groupId": "OG004", "value": "163"}, {"groupId": "OG005", "value": "157"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.8", "spread": "10.751"}, {"groupId": "OG001", "value": "1.073", "spread": "13.5"}, {"groupId": "OG002", "value": "-0.63", "spread": "11.696"}, {"groupId": "OG003", "value": "-0.719", "spread": "10.77"}, {"groupId": "OG004", "value": "-0.548", "spread": "11.144"}, {"groupId": "OG005", "value": "-1.176", "spread": "13.398"}]}]}, {"title": "Day 14", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "49"}, {"groupId": "OG001", "value": "27"}, {"groupId": "OG002", "value": "40"}, {"groupId": "OG003", "value": "36"}, {"groupId": "OG004", "value": "37"}, {"groupId": "OG005", "value": "32"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.109", "spread": "15.101"}, {"groupId": "OG001", "value": "0.599", "spread": "16.387"}, {"groupId": "OG002", "value": "1.842", "spread": "14.988"}, {"groupId": "OG003", "value": "-1.324", "spread": "13.666"}, {"groupId": "OG004", "value": "0.423", "spread": "11.247"}, {"groupId": "OG005", "value": "-3.969", "spread": "13.715"}]}]}, {"title": "Day 30", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "176"}, {"groupId": "OG001", "value": "143"}, {"groupId": "OG002", "value": "138"}, {"groupId": "OG003", "value": "147"}, {"groupId": "OG004", "value": "145"}, {"groupId": "OG005", "value": "139"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.294", "spread": "13.61"}, {"groupId": "OG001", "value": "1.064", "spread": "14.128"}, {"groupId": "OG002", "value": "0.435", "spread": "13.63"}, {"groupId": "OG003", "value": "-0.349", "spread": "12.636"}, {"groupId": "OG004", "value": "-0.802", "spread": "11.311"}, {"groupId": "OG005", "value": "-1.633", "spread": "12.719"}]}]}, {"title": "Day 60", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "155"}, {"groupId": "OG001", "value": "128"}, {"groupId": "OG002", "value": "130"}, {"groupId": "OG003", "value": "129"}, {"groupId": "OG004", "value": "139"}, {"groupId": "OG005", "value": "131"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0.297", "spread": "13.033"}, {"groupId": "OG001", "value": "-0.975", "spread": "14.953"}, {"groupId": "OG002", "value": "-1.741", "spread": "10.86"}, {"groupId": "OG003", "value": "-2.318", "spread": "14.225"}, {"groupId": "OG004", "value": "0.192", "spread": "13.377"}, {"groupId": "OG005", "value": "-1.608", "spread": "13.828"}]}]}, {"title": "Day 90", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "141"}, {"groupId": "OG001", "value": "119"}, {"groupId": "OG002", "value": "121"}, {"groupId": "OG003", "value": "121"}, {"groupId": "OG004", "value": "131"}, {"groupId": "OG005", "value": "122"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.189", "spread": "12.289"}, {"groupId": "OG001", "value": "-1.647", "spread": "13.001"}, {"groupId": "OG002", "value": "-2.89", "spread": "12.034"}, {"groupId": "OG003", "value": "-2.212", "spread": "12.041"}, {"groupId": "OG004", "value": "-0.71", "spread": "13.777"}, {"groupId": "OG005", "value": "-1.145", "spread": "14.284"}]}]}, {"title": "Premature discontinuation", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "36"}, {"groupId": "OG001", "value": "24"}, {"groupId": "OG002", "value": "24"}, {"groupId": "OG003", "value": "23"}, {"groupId": "OG004", "value": "25"}, {"groupId": "OG005", "value": "23"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.278", "spread": "15.909"}, {"groupId": "OG001", "value": "-1.424", "spread": "15.587"}, {"groupId": "OG002", "value": "-0.222", "spread": "7.591"}, {"groupId": "OG003", "value": "1.101", "spread": "10.22"}, {"groupId": "OG004", "value": "4.733", "spread": "13.646"}, {"groupId": "OG005", "value": "-2.072", "spread": "19.731"}]}]}, {"title": "Follow-up", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "165"}, {"groupId": "OG001", "value": "131"}, {"groupId": "OG002", "value": "141"}, {"groupId": "OG003", "value": "135"}, {"groupId": "OG004", "value": "153"}, {"groupId": "OG005", "value": "143"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.281", "spread": "13.789"}, {"groupId": "OG001", "value": "-2.057", "spread": "13.982"}, {"groupId": "OG002", "value": "-0.626", "spread": "14.196"}, {"groupId": "OG003", "value": "-1.326", "spread": "15.488"}, {"groupId": "OG004", "value": "0.834", "spread": "14.159"}, {"groupId": "OG005", "value": "-1.317", "spread": "14.636"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Adverse events: from the start of study treatment until 3 days post-last dose, up to approximately 93 days. All Cause Mortality: assessed until 30 days post-last dose, up to approximately 120 days.", "eventGroups": [{"id": "EG000", "title": "Eplerenone (INSPRA\u00ae)", "description": "Eplerenone 25 milligram (mg) capsule every other day (EOD), on Day 1, Day 3, Day 5, etc, along with placebo capsule (matched to Eplerenone capsule) on Day 2, Day 4, Day 6, etc., and placebo tablet (matched to Finerenone tablet) once daily (OD).The dose could be increased to 25 mg OD at Day 30 and to 50 mg OD at Day 60 (or 25 mg OD if no up-titration occurred on Day 30) if both up-titration steps were performed. Treatment duration was for 90 days.", "deathsNumAffected": 19, "deathsNumAtRisk": 221, "seriousNumAffected": 77, "seriousNumAtRisk": 221, "otherNumAffected": 85, "otherNumAtRisk": 221}, {"id": "EG001", "title": "Finerenone(BAY94-8862) 2.5-5 mg OD", "description": "Finerenone 2.5 mg immediate-release (IR) tablets OD and placebo-matched to Eplerenone capsule OD, with possible up-titration to 5 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days.", "deathsNumAffected": 17, "deathsNumAtRisk": 172, "seriousNumAffected": 72, "seriousNumAtRisk": 172, "otherNumAffected": 63, "otherNumAtRisk": 172}, {"id": "EG002", "title": "Finerenone (BAY94-8862) 5-10 mg OD", "description": "Finerenone 5 mg IR tablets OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 10 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days.", "deathsNumAffected": 9, "deathsNumAtRisk": 163, "seriousNumAffected": 47, "seriousNumAtRisk": 163, "otherNumAffected": 59, "otherNumAtRisk": 163}, {"id": "EG003", "title": "Finerenone (BAY94-8862) 7.5-15 mg OD", "description": "Finerenone 7.5 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 15 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days.", "deathsNumAffected": 12, "deathsNumAtRisk": 167, "seriousNumAffected": 52, "seriousNumAtRisk": 167, "otherNumAffected": 50, "otherNumAtRisk": 167}, {"id": "EG004", "title": "Finerenone (BAY94-8862) 10-20 mg OD", "description": "Finerenone 10 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days.", "deathsNumAffected": 2, "deathsNumAtRisk": 169, "seriousNumAffected": 46, "seriousNumAtRisk": 169, "otherNumAffected": 50, "otherNumAtRisk": 169}, {"id": "EG005", "title": "Finerenone (BAY94-8862) 15-20 mg OD", "description": "Finerenone 15 mg IR tablet OD and placebo capsule (matched to Eplerenone capsule) OD, with possible up-titration to 20 mg OD at Day 30 (Day 30\u00b12) and sham up-titration at Day 60 (Day 60\u00b12). Treatment duration was for 90 days.", "deathsNumAffected": 9, "deathsNumAtRisk": 163, "seriousNumAffected": 57, "seriousNumAtRisk": 163, "otherNumAffected": 65, "otherNumAtRisk": 163}], "seriousEvents": [{"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Acute myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Atrial flutter", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Atrial tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 2, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Atrioventricular block complete", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cardiac arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 2, "numAffected": 2, "numAtRisk": 163}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 27, "numAffected": 21, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 26, "numAffected": 16, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 17, "numAffected": 15, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 33, "numAffected": 21, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 12, "numAffected": 11, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 14, "numAffected": 13, "numAtRisk": 163}]}, {"term": "Cardiac failure acute", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 4, "numAffected": 3, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 5, "numAffected": 5, "numAtRisk": 163}]}, {"term": "Cardiac failure chronic", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 16, "numAffected": 13, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 11, "numAffected": 9, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 7, "numAffected": 7, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 9, "numAffected": 8, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 6, "numAffected": 6, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 16, "numAffected": 12, "numAtRisk": 163}]}, {"term": "Cardiac failure congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 4, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 2, "numAffected": 2, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 7, "numAffected": 3, "numAtRisk": 163}]}, {"term": "Cardiogenic shock", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Coronary artery disease", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Coronary artery occlusion", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Coronary artery stenosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Left ventricular failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Mitral valve incompetence", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Myocardial ischaemia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Pericardial haemorrhage", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Right ventricular failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Sick sinus syndrome", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Supraventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Ventricular arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Ventricular fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Ventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 8, "numAffected": 4, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 5, "numAffected": 3, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Left ventricular dysfunction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cardiopulmonary failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Acute coronary syndrome", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cardiac ventricular thrombosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Ventricular tachyarrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cardiovascular insufficiency", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Hyperthyroidism", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cataract", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cataract nuclear", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Vitreous haemorrhage", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Constipation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Gastritis erosive", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Inguinal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Pancreatitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Small intestinal perforation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Intestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Malaise", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Sudden death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Sudden cardiac death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Oedema due to cardiac disease", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 2, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Implant site haematoma", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Implant site ulcer", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Stent-graft endoleak", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Acute hepatic failure", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Hepatitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Bronchopneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Endocarditis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Erysipelas", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Gastrointestinal infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 2, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Lymphangitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Necrotising fasciitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Osteomyelitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 3, "numAffected": 3, "numAtRisk": 163}]}, {"term": "Pneumonia legionella", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 2, "numAffected": 2, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Septic shock", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Rectal abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Staphylococcal bacteraemia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Pneumococcal sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Asymptomatic bacteriuria", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Escherichia infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Respiratory tract infection viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Enterocolitis bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Accident", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Femur fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Hip fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Incisional hernia", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Overdose", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Subdural haematoma", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Brain contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Allergic transfusion reaction", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Toxicity to various agents", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Blood creatinine increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Blood potassium increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 2, "numAffected": 2, "numAtRisk": 163}]}, {"term": "International normalised ratio increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Computerised tomogram abdomen abnormal", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Troponin T increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Hepatic enzyme increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Dehydration", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Hyperkalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 7, "numAffected": 7, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 5, "numAffected": 5, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 6, "numAffected": 6, "numAtRisk": 163}]}, {"term": "Hypoglycaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Hypokalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 2, "numAffected": 2, "numAtRisk": 163}]}, {"term": "Hyponatraemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Hypovolaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Type 2 diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Muscle haemorrhage", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Rhabdomyolysis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Metastases to liver", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Rectal adenocarcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Lung neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cerebellar syndrome", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Embolic stroke", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Haemorrhage intracranial", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Loss of consciousness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Nervous system disorder", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Status epilepticus", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Vocal cord paralysis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cerebrovascular insufficiency", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Ischaemic stroke", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Completed suicide", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Delirium", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Sleep disorder", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Mental status changes", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Psychotic disorder", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Azotaemia", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Haematuria", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Nephrolithiasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Nephropathy toxic", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Renal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Renal failure acute", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 4, "numAffected": 4, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Renal failure chronic", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 2, "numAffected": 2, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 3, "numAffected": 3, "numAtRisk": 163}]}, {"term": "Renal impairment", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Benign prostatic hyperplasia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Acute pulmonary oedema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Choking", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Dyspnoea exertional", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Epistaxis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Lung disorder", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Pleural effusion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Pneumonitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Pulmonary embolism", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Pulmonary oedema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 4, "numAffected": 2, "numAtRisk": 163}]}, {"term": "Respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Obstructive airways disorder", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Skin ulcer", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Stasis dermatitis", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Diabetic foot", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cardiac pacemaker insertion", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cardiac pacemaker removal", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cardioversion", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Foot amputation", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Toe amputation", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Implantable defibrillator insertion", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Ventricular assist device insertion", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Cardiac rehabilitation therapy", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Cardiac resynchronisation therapy", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Cardiac ablation", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 2, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Tooth extraction", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Percutaneous coronary intervention", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Aortic stenosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Circulatory collapse", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Orthostatic hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Peripheral ischaemia", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 2, "numAffected": 1, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Deep vein thrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 163}]}, {"term": "Femoral artery occlusion", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}, {"term": "Haemodynamic instability", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 163}]}], "otherEvents": [{"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 14, "numAffected": 13, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 20, "numAffected": 14, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 11, "numAffected": 10, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 6, "numAffected": 5, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 7, "numAffected": 7, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 10, "numAffected": 10, "numAtRisk": 163}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 6, "numAffected": 6, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 11, "numAffected": 10, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 6, "numAffected": 6, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 9, "numAffected": 7, "numAtRisk": 163}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 12, "numAffected": 9, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 7, "numAffected": 5, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 6, "numAffected": 6, "numAtRisk": 163}]}, {"term": "Blood creatinine increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 14, "numAffected": 12, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 7, "numAffected": 7, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 3, "numAffected": 3, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 4, "numAffected": 4, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 9, "numAffected": 8, "numAtRisk": 163}]}, {"term": "Hyperkalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 8, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 10, "numAffected": 7, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 7, "numAffected": 7, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 6, "numAffected": 6, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 9, "numAffected": 9, "numAtRisk": 163}]}, {"term": "Hypokalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 44, "numAffected": 34, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 26, "numAffected": 20, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 28, "numAffected": 21, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 30, "numAffected": 15, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 18, "numAffected": 14, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 20, "numAffected": 17, "numAtRisk": 163}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 12, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 8, "numAffected": 8, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 7, "numAffected": 6, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 6, "numAffected": 6, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 7, "numAffected": 7, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 7, "numAffected": 6, "numAtRisk": 163}]}, {"term": "Renal impairment", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 8, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 8, "numAffected": 6, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 9, "numAffected": 7, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 10, "numAffected": 6, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 11, "numAffected": 8, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 9, "numAffected": 9, "numAtRisk": 163}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 12, "numAffected": 11, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 13, "numAffected": 12, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 7, "numAffected": 7, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 7, "numAffected": 6, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 4, "numAffected": 3, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 11, "numAffected": 10, "numAtRisk": 163}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 11, "numAtRisk": 221}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 172}, {"groupId": "EG002", "numEvents": 12, "numAffected": 11, "numAtRisk": 163}, {"groupId": "EG003", "numEvents": 14, "numAffected": 11, "numAtRisk": 167}, {"groupId": "EG004", "numEvents": 7, "numAffected": 7, "numAtRisk": 169}, {"groupId": "EG005", "numEvents": 8, "numAffected": 8, "numAtRisk": 163}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true}, "pointOfContact": {"title": "Therapeutic Area Head", "organization": "Bayer HealthCare AG", "email": "clinical-trials-contact@bayer.com"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Czech Republic"]}, "conditionBrowseModule": {"meshes": [{"id": "D000007674", "term": "Kidney Diseases"}, {"id": "D000051436", "term": "Renal Insufficiency, Chronic"}, {"id": "D000006333", "term": "Heart Failure"}, {"id": "D000018487", "term": "Ventricular Dysfunction, Left"}, {"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000003924", "term": "Diabetes Mellitus, Type 2"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}, {"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000014570", "term": "Urologic Diseases"}, {"id": "D000052776", "term": "Female Urogenital Diseases"}, {"id": "D000005261", "term": "Female Urogenital Diseases and Pregnancy Complications"}, {"id": "D000091642", "term": "Urogenital Diseases"}, {"id": "D000052801", "term": "Male Urogenital Diseases"}, {"id": "D000051437", "term": "Renal Insufficiency"}, {"id": "D000002908", "term": "Chronic Disease"}, {"id": "D000020969", "term": "Disease Attributes"}, {"id": "D000010335", "term": "Pathologic Processes"}, {"id": "D000018754", "term": "Ventricular Dysfunction"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M7119", "name": "Diabetes Mellitus, Type 2", "asFound": "Type 2 Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M7796", "name": "Emergencies", "relevance": "LOW"}, {"id": "M10698", "name": "Kidney Diseases", "asFound": "Kidney Disease", "relevance": "HIGH"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M27583", "name": "Systolic Murmurs", "relevance": "LOW"}, {"id": "M26717", "name": "Renal Insufficiency, Chronic", "asFound": "Chronic Kidney Disease", "relevance": "HIGH"}, {"id": "M26718", "name": "Renal Insufficiency", "relevance": "LOW"}, {"id": "M20824", "name": "Ventricular Dysfunction", "relevance": "LOW"}, {"id": "M20591", "name": "Ventricular Dysfunction, Left", "asFound": "Left Ventricular Systolic Dysfunction", "relevance": "HIGH"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M17319", "name": "Urologic Diseases", "relevance": "LOW"}, {"id": "M2875", "name": "Urogenital Diseases", "relevance": "LOW"}, {"id": "M27093", "name": "Female Urogenital Diseases", "relevance": "LOW"}, {"id": "M14127", "name": "Pregnancy Complications", "relevance": "LOW"}, {"id": "M8399", "name": "Female Urogenital Diseases and Pregnancy Complications", "relevance": "LOW"}, {"id": "M27095", "name": "Male Urogenital Diseases", "relevance": "LOW"}, {"id": "M6147", "name": "Chronic Disease", "relevance": "LOW"}, {"id": "M22700", "name": "Disease Attributes", "relevance": "LOW"}, {"id": "T1303", "name": "Chronic Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "BXS", "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"}, {"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000077545", "term": "Eplerenone"}], "ancestors": [{"id": "D000000451", "term": "Mineralocorticoid Receptor Antagonists"}, {"id": "D000006727", "term": "Hormone Antagonists"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000062865", "term": "Diuretics, Potassium Sparing"}, {"id": "D000004232", "term": "Diuretics"}, {"id": "D000045283", "term": "Natriuretic Agents"}, {"id": "D000000959", "term": "Antihypertensive Agents"}], "browseLeaves": [{"id": "M1823", "name": "Eplerenone", "asFound": "Onset of", "relevance": "HIGH"}, {"id": "M3797", "name": "Mineralocorticoid Receptor Antagonists", "relevance": "LOW"}, {"id": "M11871", "name": "Mineralocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M7411", "name": "Diuretics", "relevance": "LOW"}, {"id": "M30025", "name": "Diuretics, Potassium Sparing", "relevance": "LOW"}, {"id": "M4277", "name": "Antihypertensive Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AnAg", "name": "Antihypertensive Agents"}, {"abbrev": "NaAg", "name": "Natriuretic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}